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ABSTRACT 
In the United States, 1 out of every 9 death certificates in 2013 referenced heart 
failure.1 Despite the outstanding need of treatment options for heart failure, heart 
transplantation remains the optimal treatment method. However, there is a severe 
shortage of donor hearts available for transplantation.2 Other available treatment options 
are not ideal because they do not fully restore function and are associated with creating 
other complications.3 Thus, there is a need for developing a living tissue engineered 
whole heart for transplantation to provide an alternative option for patients on the waitlist 
to receive a donor heart. 
Our solution is to create acellular myocardial tissue scaffolds seeded with 
autologous cells corresponding to the patient’s heart. Once the cell seeded scaffold is 
conditioned and prepared to support life, it would not elicit an immune response post-
implantation. The goal of this project is to reconstitute the endocardium in both ventricles 
of decellularized rabbit myocardium with clinically relevant cell types and hydrogels.  
We first developed a bi-ventricle perfusion decellularization procedure which 
yielded fully acellular hearts. The shape, architecture, and most of the extracellular 
matrix components of the scaffolds were preserved. Some minor drawbacks included 
partial removal of the basal lamina components and increased scaffold porosity.  
Next, we performed a series of cell seeding and hydrogel infusion experiments to 
develop a procedure for delivering the necessary components for rebuilding the 
endocardium. To help us reach our goal, several devices were designed and developed 
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along the way including a 3-D printed stand and funnel for gravitational seeding and a 
rotational bioreactor system. Our final procedure utilized a layer-by-layer method for 
administering human endothelial cells, human fibroblast cells, collagen hydrogel, and 
fibrin hydrogel. Using different analysis techniques, we found hydrogels infused onto the 
surfaces of the ventricle cavities and cells affectively adhered to the linings of ventricles 
while remaining active through secreting matrix proteins. However, we could not fully 
cover the entire surfaces of the ventricles with our tissue engineered endocardium. Future 
work will be geared towards developing a uniform inner lining of the ventricles. 
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CHAPTER ONE 
INTRODUCTION 
1.1 Background  
1.1.1 Anatomy 
The heart wall is composed of three layers. The epicardium forms the outside 
layer of the heart, the myocardium forms the middle layer of the heart, and the 
endocardium forms the inside layer of the heart. Each layer is composed of a unique 
composition and structural that serves a specific function required to maintain a healthy 
heart. 
Briefly, the epicardium or visceral pericardium, forms the outer membrane of the 
heart. Along with the parietal pericardium, the epicardium lines the pericardial cavity. 
The epicardium can be divided into two layers. A mesothelium layer covers the entire 
surface of the pericardial cavity and forms the outermost portion of the epicardium. 
Underneath the mesothelium surface of the epicardium, areolar connective tissue forms 
the subepicardial layer and intimately adjoins to the myocardium.4,5 Both adipose and 
fibrous connective tissue constitute the areolar connective tissue. Inside the subepicardial 
layer several lymphatic vessels, blood vessels, and nerves can be found.5 
The primary function of the heart is to pump blood through the circulatory 
system. Repeated diastolic and systolic rhymes that make up the contractions are 
governed by the myocardium. Electrochemical stimulations induce the cardiac muscle 
fibers to contract and force the movement of blood. Purkinje fibers integrated into the 
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heart muscle are responsible for this stimulation and serve to maintain synchronized 
contractions amongst the cardiac muscle fibers. The myocardium is the thickest layer of 
the heart that lies in between the epicardium and endocardium. However, the thickness of 
the myocardium is not universal for each of the four chambers of the heart. The pressure 
present in each chamber correlates to the thickness of that chamber.5 Cardiomyocytes are 
the primary cell type found in the myocardium. Cardiac muscle fibers are formed by 
cardiomyocytes connected in a long row adjoined to each other by intercalated discs. 
Interestingly, in the left ventricle, cardiac muscle fiber angles transition from epicardium 
to endocardium. The cardiac muscle fiber angles vary from about -60˚ from the 
circumferential axis at the epicardium to about +70˚ from the circumferential axis at the 
endocardium.6 
The endocardium is the focus of this project and will be the emphasis of the 
remainder of the anatomy subchapter. The endocardium is a multilayered tissue that has 
been established since the nineteenth century when Bouillaud coined the term 
endocardium to contrast the internal membrane of the heart with the pericardium.7 There 
are two layers that comprise the endocardium. The first is the endothelium. Endothelial 
cells are polygonal squamous and form tight junctions with one another to create a 
monolayer that encompasses the full blood contacting surface of each chamber of the 
heart.8 The endothelium functions to prevent thrombosis from forming similar to the 
endothelium found in blood vessels. Beneath the endothelial monolayer exists an electron 
dense basal lamina for connecting endothelial cells to the underlying tunica propria.8,9 
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The tunica propria is the second layer of the endocardium. In this layer, fibroblast 
become the most prominent cell type.8 This subendothelial layer is constructed by loose 
connective tissue with unmyelinated nerve fibers dispersed throughout. The loose 
connective tissue is primarily composed of collagen in single or multiple unit fibrils 
arranged either parallel to the ventricular surface or randomly oriented in the ground 
substance.8 Nagayo (1909) described the tunica propria as divided into 3 or 4 sublayers 
depending on the chamber of the heart. In the left ventricle, the first sublayer is an inner 
connective tissue layer followed by an elastic sublayer. Beneath the elastic sublayer, there 
is a smooth muscle sublayer and an additional connective tissue sublayer before reaching 
the myocardium. However, in the atria, the smooth muscle sublayer does not exist.10 
Interestingly, in rat hearts, Melax (1967) did not find an elastic sublayer. Instead, he only 
found elastic clumps at the junction between the aorta and the endocardium.8 This 
suggest a slight difference in endocardial anatomy between mammalian species. At the 
border of the endocardium and the myocardium, the endocardium is anchored by the unit 
membrane of muscle cells that act as both sarcolemma and an extracellular basement 
membrane.8 
The overall surface of the endocardium is extremely irregular. Papillary muscles 
and trabeculae carneae form random orientations by crisscrossing along the surface. 
Interlacing fiber bundles create a curvy membrane consistent with multiple bulging 
portions and valleys in between.11,12 In the human heart, the thickness of the endocardium 
slightly varies within each chamber and greatly varies among chambers. OKADA (1961) 
found the average thickness to be 10µm-20µm in the left ventricle, 7µm-10µm in the 
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right ventricle, 300µm and 100µm in the left and right atrium respectively. Additionally, 
he found there are correlations for increasing thickness of the endocardium with 
increasing age of the person and increasing thickness of the aortic valvular leaflet.13 
 
Figure 1: The anatomy and structure of the heart wall. The endocardium is 
positioned on the left side beginning with the endothelium. In the middle, the 
myocardium is shown. The right side depicts the pericardium, pericardial cavity, and 
epicardium.  Image courtesy of anatomygroup.wordpress.com  
Throughout history, the endocardium has been neglected amongst researchers. 
This is in part because the endocardium has been regarded as only having the function of 
an endothelium. However, the endocardium may function as more than a tightly sealed 
blood contacting surface. In fact, the endocardium may provide feedback to modulate the 
myocardium’s mechanical performance through direct exposure to the circulating 
bloodstream.12,14 Regulation of ion and water exchange between the myocardium and 
bloodstream may be an additional function of the endocardium. Although much of this 
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substance exchange may occur via the coronary vasculature, the intercellular clefts in 
between the endothelial cells of the endocardial endothelium may play a role in 
regulating this ion/water flux through variations in cleft size.12  The endocardium has 
been suggested to be more intimately involved with myocardium than previously thought. 
Through direct or in-direct pathways, the endocardium may act as a sensory mechanism 
to influence cardiac performance.12 However, due to lack of research conducted on the 
endocardium, these mentioned functions lack the evidence to be proven.  
Although much of the endocardium’s functions remain unknown or unproven, 
there has been sufficient evidence to show a correlation between diseases of the heart and 
health of the inner membrane of the heart. Pathological consequence of various diseases 
have been shown to impact the endocardium.13 Myocardial Infarction (MI), dilation, 
hypertrophy, endocarditis, and unusually high jet stream have been shown to be 
disruptive to the endocardium.13,15,16 Damage to the endocardium leads down a pathway 
towards thrombogenic fibrosis and eventually endocardial thickening.13 Ultimately, due 
to the high rate of occurrence for MI each year, MI may be responsible for many cases of 
endocardial thickening worldwide.  
 
1.1.2 Etiology  
Myocardial Infarction (MI) is a disease responsible for many deaths and 
disabilities across the world. More than 7 million people worldwide are estimated to have 
some form of MI each year17. In Europe, every seventh woman and every sixth man will 
die due to MI.18 In the United States close to 900,000 people are diagnosed with MI each 
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year and close to a quarter of them die.19 After the first few hours following MI, many 
patients die due to ventricle fibrillation because they are unable to make it to the hospital 
in time for treatment.18  
There are many causes of MI. The most common cause of MI occurs due to 
partial or complete occlusion in a coronary artery from erosion or rupture of plaques, 
which causes 70% of deaths related to MI.17,20 Other common causes of MI occur from 
emboli, coronary spasm, or dissection of a coronary artery.20 According to a study by 
Yusuf (2004), several risks factors have been identified for attributing to the occurrence 
of MI. He determined nine risk factors, which can be potentially altered through 
treatments and lifestyle changes, attributing to 90% of the risk of the first occurrence of 
acute MI. These nine risk factors are: smoking, consumption of fruit and vegetables, 
alcohol consumption, exercise, diabetes, hypertension, dyslipidemia, abdominal obesity, 
and psychosocial. He discovered smoking and dyslipidemia are the two most impactful of 
the risk factors.21 
MI was identified as a disease in the 1970s and characterized by plaque rupturing, 
causing thrombosis, and resulting in the occlusion of a vessel in the coronary 
vasculature.22 Since then, mostly due to the advancement of technology available to 
clinicians, extensive research into the topic, and new treatment options, the definition of 
MI has evolved to encompass multiple circumstances leading to myocardial ischemia.  
Five classifications have developed for the different types of MI identified since 
the 1970s. The first type is as mentioned previously in this paper, caused by plaque 
erosion/rupture. The second type is caused by lack of oxygen supply.23 Oxygen demand 
 7 
in the myocardium can change due to arrhythmias, coronary artery spasm, hypertension, 
and other factors. The third classification results in an unexpected death of the patient 
with signs of myocardial ischemia.23 In this scenario, the patient died before blood 
samples could be analyzed or imaging techniques could be used to identify MI. The 
fourth and fifth type of MI occurs to due intervention. The fourth pertaining to 
percutaneous coronary intervention (PCI) or stent thrombosis and the fifth pertaining to 
coronary artery bypass graft (CABG) procedure.23 Across all five classifications of MI 
the common theme linking them all together is cardiac myocyte death due to ischemia.   
 
Figure 2: Depiction of MI. An occluded coronary artery causes an ischemic area 
downstream of the occlusion in the myocardium. Image courtesy of nurseslabs.com 
 
Pathology 1.1.3 
Once a patient has been diagnosed with a type of MI, the disease can be further 
classified by considering the pathological features presented by the patient. MI can be 
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identified pathologically as acute, in the progress of healing, or healed.23 Typically acute 
MI is the optimal condition for reperfusion to minimize cardiac cell death and healing MI 
is the optimal condition for regenerative treatments to minimize the remodeling process.  
From the moment ischemia occurs up to six hours, the pathological identification 
is acute MI.23 After six hours, the cytokines released by injured myocytes recruit 
fibroblasts and mononuclear cells through chemotaxis to the ischemic area and induces 
fibroblast proliferation.17,19,23 When these cells are present, MI can be pathologically 
classified as healing.23 According to Sutton (2000), the growth factors released by 
macrophages and necrotic myocytes induce the fibroblast to differentiate into 
myofibroblasts. Remodeling then takes place through collagen degradation by matrix 
metalloproteinases and secretion of collage type I and III by the differentiated 
myofibroblasts. After the fibrous tissue replaces the necrotic tissue, collagen formation 
becomes less occurrent and myofibroblasts are induced to partake in apoptosis.24 Once 
acellular fibrous scar tissue has formed, typically occurring after 5-6 weeks, MI is 
considered healed.23  
Myocardial tissue is less capable of regeneration compared to other tissues in the 
body.25 After myocytes undergo necrosis, the heart experiences an increase in loading 
conditions and wall stresses. Through biochemical signaling, these loading conditions are 
counteracted by the formation of acellular scar tissue, dilation, and hypertrophy.24 
Hypertrophy and the enlargement of the ischemic area occurs through degradation of 
collagen struts causing slippage of necrotic myocytes.24,26 Remodeling and the formation 
of scar tissue will continue until elevated wall stresses are evenly distributed by the 
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collagen scar tissue and the distending forces and increased loading conditions are 
balanced.24 The extent of collagen cross-linking to strengthen the acellular fibrous tissue 
is determined by the mechanical stimuli experienced by remodeled area.27 Hypertrophy, 
dilation, and formation of acellular scar tissue will ultimately lead towards congestive 
heart failure. A big clinical challenge dealing with MI is preventing scar tissue formation 
and impeding progress towards congestive heart failure (CHF). 
 
1.1.4 Diagnosis  
Diagnosis is important for treating MI. Having the capability of identifying and 
locating small areas of myocardial necrosis will improve patient outcomes by recognizing 
the need for treatment prior to the progression of unfavorable cardiac function during the 
remodeling phase. It is important to classify MI into two categories to be referenced later, 
ST-segment elevations myocardial infarction (STEMI) and non-ST-segment elevations 
myocardial infarction (NSTEMI). These classifications are created based on the method 
used to diagnose MI. STEMI refers to the PQRST wave on an electrocardiogram. 
Patients experiencing MI will sometimes exhibit an extended period between the ending 
of the QRS wave and the beginning of the T wave. NSTEMI refers to patients that do not 
exhibit this apparent change in the PQRST wave but are still diagnosed with MI. 
Additional diagnostic methods used to identify MI in patients are evaluation of 
biomarkers and imaging techniques.  
Damaged myocytes release different proteins into the blood circulation that can 
be evaluated as biomarkers, such proteins include cardiac troponin T and I, LDH, CK, 
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CKMB, myoglobin and others.28 Out of these biomarkers, the most reliable is troponin I 
and T. Troponin I and T are highly specific to myocardial tissue and can be used to 
identify small areas of myocardial necrosis.23 The second-best biomarker to use for 
diagnosing MI is CKMB. CKMB is primarily secreted in cardiac tissue but can also be 
found in skeletal tissue.23 The lack of exclusive secretion in myocardial tissue may lead 
to a missed diagnosis using CKMB. The worst biomarker to use for MI is CK because it 
is not very specific to myocardium and has a large prevalence in skeletal muscle.23  
Multiple imaging techniques can be used for diagnosing MI and present the 
advantage of being noninvasive.  Frequently used imaging techniques are radionuclide, 
myocardial perfusion scintigraphy, echocardiography, ventriculography, and magnetic 
resonance imaging. Less frequent imaging techniques used are X-ray computed 
tomography and positron emission tomography.23 A more invasive but frequently used 
imaging technique is angiography. In this technique, a contrast die is released from a 
catheter in front of the coronary arteries in the aorta. The die will flow through the 
coronary vasculature visualized by X-ray imaging. Areas of occlusion are easily 
recognizable using this approach. Compatibility with PCI is another big advantage of 
angiography. Using this technique, PCI can be administered immediately following the 
recognition of an occluded coronary artery. 
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Figure 3: Depiction of an angiogram. A catheter releases a radiopaque die in front of 
the coronary arteries. X-ray imaging is then used to discover areas of occlusion (arrows). 
Image courtesy of shalby.org 
 
1.2 Current Treatment Options  
1.2.1 Coronary Artery Bypass Graft (CABG) 
CABG was developed in 1968 and became the gold standard for treating coronary 
artery disease29. However, this procedure’s surgery rate has been steadily declining since 
the early 2000s.30,31 Currently, there is a small number of patients who undergo CABG 
with STEMI. CABG is required for MI patients whose anatomy is not compatible with 
PCI. Also, the patency of the occlude artery must allow for enough time for the MI 
patients to be transferred to a surgical team.18 Therefore, CABG is used to treat coronary 
artery disease but not frequently used as the first choice of treatment for MI. 
The invasiveness, recovery time, and time between first medical contact and 
successful reperfusion are the biggest disadvantages associated with CABG. During 
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CABG, a blood vessel must be dissected from the patient and sewed onto the heart. The 
blood vessel is usually cut from the saphenous vein or chest wall. To sew the graft onto 
the heart, one end of the blood vessel is attached to the aorta and the other end is attached 
downstream of the occluded coronary artery. This allows for a bypass of the blockage in 
the coronary artery by restoring blood flow to the ischemia area affected by the 
occlusion. 
 
Figure 4: Coronary Artery Bypass Grafting (CABG). A coronary artery bypass graft 
is attached to the aorta and attached downstream of the coronary artery occlusion. Image 
courtesy of hopelandmedicaltourism.com 
 
1.2.2 Fibrinolysis and Thrombolysis  
Fibrinolysis and thrombolysis utilize drugs to dissolve the blood clot causing the 
occlusion in the coronary vessel. The difference between the two techniques are the 
targeted components of the blood clot. Fibrinolysis targets the fibrin content and 
thrombolysis targets the thrombin content. Streptokinase and tissue plasminogen activator 
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are examples of drugs used for fibrinolysis. Unfractionated heparin is an example of a 
drug used for thrombolysis. These drugs can be administered intravenously or through a 
catheter at the location of the clot. Additionally, the catheter can be equipped with a 
mechanical device used to physically break up the clot. Thrombolysis and Fibrinolysis 
have both been proven to be beneficial for patients experiencing acute MI.32,33 Majority 
of patients presenting STEMI will benefit from thrombolysis if the procedure is 
conducted within 12 hours of symptom onset.32 Decreased mortality and left-ventricular 
function perseveration have been seen in patients who undergo thrombolytic therapy as 
compared to a control.32 When compared to a placebo, fibrinolysis has been shown to 
reduce 30 early deaths for every 1000 patients if the patients are treated within 6 hours of 
symptom onset.18,33 Compared to PCI and CABG, fibrinolysis and thrombolysis can be 
administered quicker. Therefore, the relatively fast time to reperfusion is the biggest 
advantage associated with fibrinolysis and thrombolysis.  
 
Figure 5: Fibrinolysis/thrombolysis. A catheter is guided into place at the site of a 
blood clot in a peripheral vein. The catheter releases a drug to dissolve the blood clot. 
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This procedure can also be conducted for reperfusion post-MI. Image courtesy of 
saintlukeshealthsystem.org 
 
1.2.3 Percutaneous Coronary Intervention (PCI)  
PCI was first introduced in 1977.29  When PCI is the first treatment method used 
for an occurrence of MI, it is considered primary PCI. A key advantage of PCI is its 
compatibility with angiography. As previously mentioned, angiography is frequently 
used to diagnose MI. Primary PCI can be immediately administered following 
confirmation of MI diagnosis with angiography.18 When compared to thrombolysis and 
fibrinolysis, PCI has been shown to reduce the occurrence of short-term adverse cardiac 
events.17,34 However, a disadvantage of PCI is its inability to be administered as quickly 
as thrombolysis and fibrinolysis. One study by De Luca (2004) has shown that every 
minute of time delay for treating STEMI affects the one year mortality rate of the 
patients.35 This increasing mortality rate holds true for both thrombolytic and fibrinolytic 
therapies as well as primary PCI. This suggests there is a time limit for the benefits to 
hold true in waiting for primary PCI treatment as opposed to immediate treatment with 
thrombolysis or fibrinolysis, especially with high risk patients.17 Currently, primary PCI 
is considered the optimal treatment option if PCI can be administered within 120 minutes 
of first medical contact. Otherwise, fibrinolysis or thrombolysis is considered to be the 
optimal treatment given there are no contraindications associated with the patient for 
administering the fibrinolytic or thrombolytic agent.18  
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PCI can also be used as a secondary approach for treating MI. In a secondary 
approach, PCI is administered following fibrinolysis or thrombolysis. In rescue PCI, PCI 
is performed following fibrinolysis when signs of failed reperfusion are present versus 
when recurrent ischemia occurs. Lower rates of death, reinfarction, and heart failure have 
been associated with rescue PCI compared to repeat fibrinolytic therapy at a 6 month 
follow up. However, PCI as opposed to repeat fibrinolytic therapy, was associated with 
an increased risk of minor bleeding and stroke.36 Additionally, secondary PCI has been 
used as an immediate follow up to fibrinolysis. This technique is known as facilitated 
PCI. However, facilitated PCI has not shown promising results.17 
Over the years PCI has evolved to encompass several different approaches to 
restoring blood flow. Balloon angioplasty, bare metal stents, drug eluting stents, and drug 
eluting balloons are some of the different technologies that have been produced to 
improve post-surgery outcomes of PCI. The two most widely used drugs in drug eluting 
stents and balloons are sirolimus and paclitaxel. One study by Stettler (2007) compared 
the clinical outcomes of using Bare Metal Stents (BMS), Paclitaxel Eluting Stents (PES), 
and Sirolimus Eluting Stents (SES). He found each of the three types of stents had similar 
cardiac mortality, with SES being associated with a decrease risk of MI and PES being 
associated with an increase occurrence of late thrombosis.37 Additionally, one and two 
year follow up of the SPIRT IV trial38,39 showed SES to have a reduction in lesion failure, 
MI, and stent thrombosis compared to PES. When comparing Paclitaxel Eluting Balloons 
(PEB) to PES, the BELLO randomized trial40 found that both treatment options had 
similar rates of major adverse cardiac events with PEB having less lumen reduction at a 6 
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month follow up. A scenario where balloon angioplasty and drug eluting balloons may be 
preferred over stenting occurs during restenosis cases. Re-stenting vessels where 
restenosis has occurred adds an additional stent layer to the vessels. This brings up 
concerns for potential long-term effects of having multiple stent layers present in a 
coronary vessel. In a short-term follow up, re-stenting with PES was shown to be superior 
in addressing restenosis compared to balloon angioplasty. However, PES was not shown 
to be superior in addressing restenosis compared to PEB in a short-term follow up.41 This 
offers promising results for concerns with long-term use of multiple stent layers. The 
option to use balloons, stents, and drugs with PCI, in addition to being complimentary 
with angiography, makes PCI the optimal treatment to restore perfusion in the 
myocardium.  
 
Figure 6: Percutaneous Coronary Intervention (PCI). A catheter is guided into place 
at the site of the blood clot. On the left the catheter is equipped with a balloon and is 
performing balloon angioplasty. On the right the catheter is also equipped with a stent to 
leave behind after expansion. Image courtesy of myheart.com 
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1.2.4 Heart Transplantation  
Once MI progresses to CHF, patients become candidates for more invasive 
therapies including heart transplantation. Since 1967, after the first heart transplant, heart 
transplantation has become the golden standard for treating patients with end-stage heart 
disease.42 Heart transplantation requires a recently deceased allogeneic donor’s heart to 
be transplanted into the patient. Due to complications with immune rejection, the donor 
and the recipient must undergo extensive screening to ensure they are compatible. 
However, even if the donor and patient are a good match, immune rejection is still a 
major concern. Following transplantation, patients are required to take 
immunosuppressive drugs for the remainder of their lives. Even with these precautions, 
the 1-year and 5-year survival rates following heart transplantation are 81% and 69% 
respectively.42  
However, heart transplantation is not the ideal long-term treatment method. Due 
to a severe lack of donors, heart transplantation is not capable of matching the 
outstanding need for treatment. As of December 15th, 2017, 2977 heart transplants were 
performed in 2017 with 3938 candidates still remaining on wait list.2 Even though heart 
transplantation has the highest survival rates out of treatment options for patients with 
end-stage heart disease, heart transplantation cannot be relied on as the sole treatment 
option with such as severe lack of donors.    
 
1.2.5 Left Ventricular Assist Device (LVAD) 
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Left ventricular assist device (LVAD) implantation has been explored for a 
‘bridge to recovery’, ‘bridge to transplantation’, and ‘destination therapy’ for patients 
with MI. In these procedures LVADs are implanted to pump blood from the defective left 
ventricle back into circulation through the aorta. In the severe cases, early implantation of 
a LVAD is used as a ‘bridge to recovery’.  
When cardiac shock becomes prevalent, clinical studies have explored implanting 
LVADs as early as 0 to 14 days after MI as opposed to waiting until near organ failure.43. 
By alleviating work load from the myocardium, more optimal myocardial recovery can 
occur and potentially eliminate the need for a heart transplantation.44 Early LVAD 
implantation has been ruled out in the past because of a feared increase risk of mortality 
and the possibility of left ventricular recovery without surgical intervention.43 While on 
the contrary, delaying LVAD implantation may lead to less favorable outcomes because 
more time is allowed for progression towards congestive heart failure. Interestingly, one 
clinical study by Chen (1999) has suggested patients may have similar results regardless 
of late or early LVAD implantation following MI.43 These findings suggests the balance 
between the advantages and disadvantages of early versus delayed LVAD implantation 
may negate one another except for extreme cases. 
As mentioned previously, heart transplant is a treatment method incapable of 
matching the need for transplantation due to a severe lack of donor hearts. One possible 
method for improving this situation is to keep the patients alive long enough to find a 
suitable donor. This method is known as ‘bridge to transplantation’. A LVAD is 
implanted onto the patient’s heart to help support life for the remainder of their life or 
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until a suitable donor heart is found. One multicenter trial found the success rate of using 
LVADs as a ‘bridge to transplantation’ to be 82% 154 days following LVAD 
implantation. During this trial, 39.4% of patients received a heart transplant and 42.4% of 
patients continued to remain on the waitlist.45 
LVADs have also been explored as a ‘destination therapy’. Due to the lack of 
treatment options for patients with end-stage heart disease, LVADs can be used as an 
alternative to heart transplantation rather than a bridge to transplantation. In this scenario, 
LVADs are implanted without the intention of performing a heart transplant in the future. 
A follow up to the REMATCH46 clinical trial explored the survival rates of patients who 
underwent LVAD implantation for ‘destination therapy’. Their results showed 86.1%, 
56.0%, 30.9%, and 17.2% of patients were alive after the 30 day, 1 year, 2 year, and 3 
year bench marks respectively.46  
LVADs provide an alternative to patients in need of a heart transplant and have 
shown to be beneficial following implantation. However, the survival rates for LVADs 
do not match the survival rates for heart transplantation. Until there are readily available 
treatment options with higher survival rates, there is still room for improvement in 
treatment methods for patients with end-stage heart disease.  
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Figure 7: Left Ventricular Assist Device (LVAD). A LVAD is implanted and attached 
to a patient’s heart. Blood is pumped from the left ventricle to the aorta. An external 
power supply and system controller are always worn by the patient.47 
 
1.3 Cardiovascular Tissue Engineering  
1.3.1 Introduction to Cardiovascular Tissue Engineering 
Tissue engineering is a growing field offering promising avenues for new 
treatment options for MI and CHF. Different approaches for tissue engineering explore 
utilizing cellular therapy, hydrogels, and developing living functional non-thrombogenic 
cardiac tissue. These approaches serve to either repair or replace damaged myocardium 
without eliciting an immune response.  
Current research has had limited success towards implementing these tissue 
engineering approaches. Stem cells and hydrogels have been used separately and together 
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to repair damaged myocardium. However, cellular retention has been a key issue 
diminishing the potential for restoring cardiac function.  
Engineering cardiac tissue for replacing or repairing the damaged myocardium 
has been developed by combining cardiac linage cells with a compatible scaffold. 
However, the desired cardiac properties and function has yet to be attained with 
engineered cardiac tissue. Finding the optimal scaffold and method for cellular 
infiltration has been important factors contributing towards the limited success using this 
technique. Much research has been put into exploring various materials and methods that 
can be used to developed cardiac tissue. Scaffolds used in tissue engineering can be 
grouped into three types: synthetic, naturally derived, and decellularized tissue.  
Techniques used for developing cardiac tissue can be grouped into three routes. 
The first route is using a non-scaffold based approach by organizing cells in three 
dimensional aggregates. This technique relies on influencing cells to secrete their own 
extracellular matrix (ECM) to serve as a scaffold. The second route is an acellular 
scaffold based approach. By implanting an acellular scaffold into the patient, host cells 
are relied upon to infiltrate, re-organize, degrade, and vascularize the scaffold. Lastly, the 
third route, is combining a scaffold with stem/progenitor cells in vitro.48–52 
 
1.3.2 Cellular Therapy 
Stem cells and progenitor cells have been used as an experimental tissue 
engineering approach for treating MI. The goal of cellular therapy is to regenerate the 
affected area, prevent re-occlusion, and inhibit as much of the remodeling process as 
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possible. The basic rationale behind this goal is the assumption that the stem cells or 
progenitor cells have potential to repair the affected myocardial tissue. Several clinical 
studies have shown a beneficial effect on left ventricular function through a significant 
increase in left ventricular ejection fraction when using bone marrow stem cells (BMSCs) 
administered within 1-7 days following PCI compared to PCI alone.25 Interestingly, some 
studies have shown BMSCs administered later than 7 days following reperfusion 
displayed better results for left ventricular ejection fraction improvement.25,53 
Additionally, one pilot study, TOPCARE-AMI54, showed that there was no significant 
difference between administering bone marrow-derived progenitor cells versus blood 
derived progenitor cells for improving left ventricular function.  
The major disadvantage of cellular therapy in treating MI, is the lack of cellular 
adhesion and presence in the administered areas post-injection. Administration of stem 
and progenitor cells leads to cellular migration to distal organs and tissue with less than 
10% cellular retention at the injection site.25,55 To improve cellular retention, Lee (2011) 
conducted an animal study on rats where human amniotic-fluid stem cells (hAFSCs) were 
aggregated into 3-dimensional spheroids prior to injection. Cells were aggregated to 
induce extracellular protein secretion with the rationale that the secreted proteins would 
improve adhesion to the myocardium post-injection. Their results demonstrated a 19% 
cellular retention increase 4 weeks’ post-injection coupled with improved cardiac 
function and attenuated remodeling as compared to injection of dissociated hAFSCs.55 
Developing new seeding techniques to improve cellular retention can maximize the 
beneficial affects cellular therapy offers for MI. This can lead to more successful 
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regenerative approaches for restoring function to a poorly functioning myocardium and 
may become the optimal approach for treating MI post-reperfusion 
 
1.3.3 Scaffolds in Tissue Engineering  
Scaffolds can be developed using various materials. Each material has their own 
unique advantages and disadvantages. Synthetic scaffolds are made using polymers such 
as: polyurethane (PU), polycaprolactone (PCL), polylactide acid (PLA), 
polyglicerolsebacate (PGS), polyglycolic acid (PGA), and others including their co-
polymers.48–52 These synthetic polymer based scaffolds offer the advantage of custom 
designed properties such as: tensile strength, degradation rate, porosity, and elastic 
modulus.49,50,52 However, synthetic scaffolds are unfamiliar to cells and may not mimic 
the biological performance as naturally derived materials due to complications with host 
tissue integration and persistent inflammation.50,56 Interestingly, Mukherjee (2011) tried 
to compensate for this disadvantage by combining poly(L-latic acid)-co-poly(ɛ -
caprolactone) (PLACL) with collagen in an electrospun fibrous membrane. 
PLACL/collagen biomaterial was shown to respond favorably with cardiomyocytes. 
After 10 days of exposure to the biomaterial, the cardiomyocytes aligned along the 
nanofibers of the membrane.57 McDevitt (2002), treated poly(lactic-co-glycolic acid) 
(PLGA) with laminin by microcontact printing techniques. This made the 
microenvironment of the PLGA scaffold more suitable for cells such that seeded 
cardiomyocytes formed fibers similar to native tissue.58  
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Naturally derived scaffolds are made through biological polymers including: 
collagen, fibrin, chitosan, alginate, gelatin, hyaluronic acid and others.48–52 These 
naturally occurring biomaterials present a more favorable environment for cellular 
adhesion, proliferation, and differentiation. They also present the advantage of not 
eliciting a host immune response post implantation. The disadvantage of naturally 
derived scaffolds are poor physical and material properties.50 Additionally, the 
composition and architecture of native tissues will not be an identical match to naturally 
derived scaffolds. Due to these disadvantages, naturally derived scaffolds are often used 
for repairing damaged myocardium in the form of hydrogels or used in combination with 
synthetic materials for engineering new cardiac tissue.57,59  
Decellularized scaffolds are created through utilizing detergents and physical 
methods to strip native tissue of cells while preserving as much ECM as possible. These 
acellular scaffolds offer the desired microenvironment, composition, and architecture 
needed for tissue engineering.48,49 However, the disadvantage of decellularized scaffolds 
is the loss of crucial structural proteins, growth factors, and potential distortion of the 
architecture following the decellularization process.60 Producing the optimal 
decellularized scaffold is achieved through finding the balance between eliminating 
immunogenic cellular debris and preserving ECM components.51,60  
Various tissues and organs have been decellularized and used in cardiac tissue 
engineering. For example, Zhao (2010), used fragments of decellularized porcine small 
intestine submucosa to create an injectable emulsion suspended in sterile saline. Rats 
with MI were injected at the infarct region with the emulsion. The decellularized small 
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intestine submucosa emulsion improved cardiac function and increased wall thickness.61 
However, it has been demonstrated that each tissue and organ has its own unique 
microenvironment.49 This suggest that using decellularized myocardium is the most 
optimal decellularized scaffold for cardiac tissue engineering. Lu (2013) decellularized 
mouse hearts and seeded multipotential cardiovascular progenitor cells derived from 
human induced pluripotent stems cells through the aorta into the left ventricular cavity. 
After providing periodic perfusion with cell medium and growth factors for 20 days, the 
seeded multipotential cardiovascular progenitor cells differentiated into cardiac cell lines 
and the heart began beating.62 Similarly, Ott (2008) decellularized rat hearts and seeded 
neonatal cardiac cells through intramural injection. Following 8-28 days of perfusion 
culture, the rat hearts began displaying contractile and electrical responses when subject 
to stimulations.63  
 
1.3.4 Hydrogels in Tissue Engineering  
Hydrogels have been used in tissue engineering by themselves to provide 
structural support for damaged myocardium or in combination with stem/progenitor cells 
to provide attachment sites for seeded cells in addition to structural support. In fact, 
studies have shown that incorporating certain hydrogels with cellular therapy can 
increase cellular retention and survival.59 Hydrogels can be created using synthetic 
materials such as PEG, naturally derived materials such as collagen, or tissue specific 
materials such as decellularized porcine myocardial ECM.59,64 One of the advantages of 
using naturally derived materials and decellularized tissue as hydrogels is they do not 
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elicit an immune response. Dai (2005), injected collagen directly in the scar region of rats 
induced with MI. The collagen did not trigger an immune response and improved left 
ventricle stroke volume while preventing infarct expansion.65 Two other types of 
naturally derived hydrogels that have been shown to be beneficial for preserving 
myocardial function post-MI, with or without including cells, are fibrin glue and 
chitosan.59 Christman (2004), injected fibrin glue into the infarct zone of rats induced 
with MI. By itself, the fibrin glue, preserved wall thickness and cardiac function.66 Lu 
(2009) administered temperature-responsive chitosan hydrogels mixed with mouse 
embryonic stem cells by intramural injection into the infarct region of rat hearts. 
Following administration, they found an increased cellular retention and improved heart 
function.67 However, the two main limitations with fibrin glue, chitosan, and many other 
naturally derived hydrogels are lack of tissue specific extracellular microenvironment and 
incompatibility with minimally invasive delivery techniques.59,64,68  
Synthetic materials used as hydrogels offer similar advantages as when used as 
scaffolds in other tissue engineering approaches. Customizable traits such as porosity, 
degradation, and mechanical stability can be altered to make a synthetic hydrogel with 
desired properties.69 Interestingly, one synthetic material, poly(N-isopropylacrylamide) 
(PNIPAAM), has the capability to undergo phase transitions in response to temperature 
changes. At room temperature PNIPAAM is a liquid, however, at physiological 
temperatures PNIPAAM phase changes into a gel.59 This improves clinical relevance 
because thermosensitive hydrogels can be delivered mixed with growth factors and/or 
cells without surgical intervention. 
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The most promising hydrogels can be delivered minimally invasively and 
improve or preserve cardiac function post-MI. Two hydrogels that have been shown to 
have these capabilities are decellularized porcine myocardial extra cellular matrix and 
alginate.59,64,68,70 The most promising of the two is decellularized porcine myocardial 
ECM because it also presents the advantage of having a tissue specific extracellular 
microenvironment.59,64,68 A tissue specific ECM offers a promising avenue for improving 
hydrogel integration with host cells in the native myocardium and increasing cellular 
retention when administered with cardiac lineage cells. 
 
1.3.5 Cardiac Patch Approach  
A tissue engineering approach for repairing, rather than replacing damaged 
myocardium, is developing a cardiac patch. Cells are seeded onto patches of scaffold to 
give a site for cellular adhesion, improve cell survival, and induce ECM secretion and 
blood vessel formation.49,51 Once the patch is implanted onto the injured myocardium, the 
patch provides mechanical support.49–51 Leor (2000), created beating cardiac patches by 
seeding fetal rat cardiac cells on to cylindrical porous alginate scaffolds. Following 9 
weeks of implantation onto myocardial scar regions of rats with MI, the cardiac patches 
were shown to diminish LV dilation and limit cardiac function deterioration.71 
Matsubayashi (2003), used poly(ɛ-caprolactone)-co-poly(L-lactide) to synthesize a 
spongy scaffold and reinforced it with kitted poly-L-lactide fabric to create a PCLA 
patch. Vascular smooth muscle cells (SMC) were seeded onto the PCLA patches and 
cultured for 2 weeks to prepare for implantation. SMC seeded PCLA patches were 
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implanted onto the infarct zone of rats with MI for 8 weeks. Following implantation, 
SMC seeded PCLA patches were shown to attenuate LV dilation and systolic function 
deterioration.72  
 
Figure 8: Cardiac patch. Cardiac lineage cells are seeded onto a porous scaffold. 
Seeded scaffold is cultured to allow cellular attachment, proliferation, and scaffold 
remodeling. Afterwards, the cardiac patch is implanted over the damaged myocardium. 
Image courtesy of ninithi.wordpress.com   
Another technique used in developing cardiac patches is cell sheets. This non-
scaffold based approach utilizes layers of cardiac linage cells over top of each other to 
develop a patch that can be implanted over the injured myocardium. Each sheet of cells is 
cultured on 2D surface detachable magnetic particles or polymers.49 After detachment, 
cells retain their adhesion proteins, secreted ECM, and attachment to one another because 
enzymatic digestion is not used.56 Using cell sheets to create cardiac patches eliminates 
complications associated with biodegradable scaffolds, such as persistent host 
inflammatory response, because the cells secrete their own scaffold.50  
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Interestingly, Shimizu (2002) overlaid sheets of cardiomyocytes onto a collagen 
membrane to create a pulsatile cardiac patch. Upon implanting into the dorsal 
subcutaneous tissues of rats, the pulsatile cardiac patches showed similar features as 
myocardial tissue. The cardiac patches displayed gap junctions, sarcomeres, and 
desmosomes.73 However, the key disadvantage of using cell sheets to create cardiac 
patches is lack of vascularization. Without the capability of forming blood vessels 
throughout the layered cell sheets, the thickness of the patch will be limited to three cell 
sheets or 80µm in thickness.51,74 Lack of oxygen and nutrient supply will induce cells to 
undergo apoptosis once the thickness of the patch surpasses the maximum depth diffusion 
can reach.51 To compensate for this, Shimizu (2006) implanted 3-layer cardiomyocyte 
cell sheets on to rat hearts and waited for 1, 2, or 3 day intervals to implant additional 3-
layer cardiomyocyte cell sheets. They found that 3-day intervals allowed for too much 
connective tissue buildup on the outside of the first 3-layer cardiomyocyte sheet for 
electrical coupling and synchronized beating to occur with additional 3-layer 
cardiomyocyte sheets. However, 1 and 2-day intervals allowed for microvessel network 
formation to occur and additional 3-layer cardiomyocyte sheets could electrically couple 
and beat in sync with the first implanted 3-layer cardiomyocyte sheet. After repeating this 
technique for additional 3-layer cardiomyocyte sheets, they were able to stack 10 sheets 
of triple-layer cardiac patches while avoiding ischemia between the 3-layer sheets.74 
However, the obvious downside to this technique is the risk of infection using 
polysurgery and repeating an invasive surgical technique 10 times to implant so many 
sheets.  
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1.3.6 Whole Heart Tissue Engineering  
Whole heart tissue engineering has been explored using decellularized xenogeneic 
myocardial ECM as scaffolds. One of the biggest challenges in tissue engineering a 
whole heart is preventing the blood contact surface from initiating thrombosis. The 
potential of cell-seeded myocardial scaffolds will be diminished without the formation of 
a complete functional endothelium to line the ventricular cavities and coronary 
vasculature.3,75 Much of the research into creating tissue engineered whole hearts have 
been geared towards either creating beating cardiac muscle tissue with cardiomyocytes 
and stem/progenitor cells or creating non-thrombogenic cardiac tissue with endothelial 
cells and stem/progenitor cells.63,75–77 Ng (2011) decellularized mice hearts and injected 
embryonic stem cells and human mesendodermal cells derived from human embryonic 
stem cells through the aorta. Seeded hearts remained in static culture for 14 days until 
they were subcutaneously implanted into severe combined immunodeficiency mice for 2, 
4, and 6 weeks. Afterwards, the stem cells expressed cardiac-specific markers.78  
Stem cell differentiation into cardiac lineage cells demonstrates the translation 
capability of tissue engineering whole hearts from benchtop to clinical practice. To 
recellularize a whole heart, cells will have to be harvested from the host to prevent 
immune rejection upon implantation. Stem cells are the most readily available cells with 
the least harvesting complications that can be extracted from a patient and grown to 
populations large enough for recellularizing a decellularized scaffold.    
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Additionally, one study by Crawford (2012) demonstrated the potential self-life of 
decellularized myocardial scaffolds. Crawford and colleagues decellularized rat hearts 
and cryopreserved them for 1 year. They tested the cytotoxicity after thawing and 
conditioning the tissue. No change in cytotoxicity was found when compared to a control 
suggesting the applicability of cryopreservation to lengthen the self-life of decellularized 
scaffolds.79 In a clinical setting, this decreases the wait time associated with developing a 
tissue engineered whole organ by eliminating the need for decellularizing fresh tissue 
every time a patient undergoes treatment.  
 
 
Figure 9: Transformation from native heart to tissue engineered whole heart. 
Native myocardium is decellularized using chemical, enzymatic, and/or physical 
treatments. Decellularized scaffold is seeded with autologous cardiac lineage cells to 
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recellularize scaffold. Following recellularization, seeded scaffold becomes a functional 
heart.80 
To date tissue engineered whole hearts are still far from being able to function 
adequately to support life. Seeding and culturing cells on a scaffold is not a viable 
method for creating a functional tissue engineered whole heart. In attempts to further 
develop engineered cardiac tissue, bioreactors have become a recognized method for 
improving the properties of tissue engineered constructs.50 In general, bioreactors have 
the capability of monitoring and controlling the oxygen, nutrients, growth factors and 
biophysical stimuli present in the culture environment of the tissue.56 Bioreactors created 
for heart muscle can provide a combination of mechanical and electrical stimuli to 
improve function properties, ECM secretion by seeded cells, and homogeneity of the 
tissue.56,81 Static, perfusion, rotating, and mixed/turbulent flow are four categories that 
can be used to group bioreactors.81 Each category is associated with its own advantages 
and disadvantages that are better suited for different types of tissue. However, not all of 
them have been shown to induce enough diffusion to create a compact tissue with 
uniformly distributed cell density.51 Perfusion bioreactors are shown to be the most 
effective for conditioning geometrically complex tissues accustom to mechanical 
constraints in vivo such as cardiac tissue.82  
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Figure 10: Depiction of a bioreactor. Seeded myocardium is conditioned in a 
bioreactor to improve cardiac functions and tissue properties. Image courtesy of 
boston.com  
In summary, there any many current treatment options for patients with MI. Some 
treatment options focus on reperfusion following occlusion while others focus on 
repairing or replacing the function of the myocardium during the healing phase of MI. 
However, there does not exist an optimal treatment option that provides the desired 
mortality rate without a lengthy wait period to receive treatment. Tissue engineering has 
been a growing field which offers many avenues that may lead to new and improved 
treatment options for MI and CHF. However, there is still much research that needs to be 
accomplished before tissue engineering can offer a viable solution. Current tissue 
engineering strategies have associated gaps in knowledge that are halting progress 
towards achieving new or improved treatment methods. Complications associated with 
current MI treatment options and the limited success with cardiovascular tissue 
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engineering provides the need for research into new potential treatment methods for MI 
and CHF.  
 
 1.4 Project Scope, Aims, and Significance 
1.4.1 Project Scope 
Across the world, over 7 million people are estimated to be affected by MI.17 
Each year in the United States alone, around 900,000 people are diagnosed with MI.19 
The pathological progression of MI goes from acute, to healing, to healed in the injured 
region of myocardium.23 The consequences associated with this progression result in 
elevated wall stresses and loading conditions. Altered mechanical stresses and the 
formation of acellular scar tissue stimulates the onset of hypertrophy and dilation.24 
Ultimately, the repercussions of MI may lead down a pathway towards congestive heart 
failure (CHF). 
Current treatment options for MI and CHF are not ideal. In the acute phase of MI, 
reperfusion therapy is the primary treatment. Several reperfusion methods exist 
including: coronary artery bypass grafting, fibrinolysis, thrombolysis, and percutaneous 
coronary intervention. However, these treatment options solely focus on re-introducing 
blood flow into the ischemic myocardium instead of repairing the damage caused by 
ischemia. Treatment options for CHF and more severe cases of MI, such as left 
ventricular assist device (LVAD) and heart transplantation, focus on replacing the 
damaged myocardium versus healing it. LVADS are beneficial to patients but do not 
produce survival rates sufficient for an ideal treatment option.45 While heart 
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transplantation remains the golden standard for treating end stage heart diseases, the need 
for treatment is vastly unmeet by the number of transplantations occurring each year.2 
New treatment options are needed to improve survival rates of patients with CHF and 
advanced stages of MI. 
Tissue engineering is a growing field exploring new experimental treatment 
methods for MI and CHF. However, the clinical success of these avenues has been 
limited. The end goal of this research is to develop a tissue engineered whole heart 
utilizing an acellular myocardial scaffold and the patient’s own cells. This tissue 
engineered whole heart would then be used instead of an allogenic cadaveric heart during 
heart transplantation. Utilizing this technique would present two advantages over 
traditional heart transplants. One, the tissue engineered whole heart would not elicit an 
adverse immune reaction because the patient’s own cells would be used to recellularize 
the acellular scaffold. This would improve the patient’s quality of life post-
transplantation surgery because the need for administering lifelong immunosuppressant 
drugs would be eliminated. Second, the tissue engineered whole heart would be more 
readily available than an allogenic cadaveric heart. The time between approval for 
surgery and transplantation would be limited to the timespan required for harvesting the 
patient’s cells, expanding the cells in culture, seeding the cells onto the off-the-shelf 
acellular scaffold, and bioreactor conditioning of the tissue engineered whole heart.   
One of the biggest challenges in cardiovascular tissue engineering is developing 
an anti-thrombogenic surface.3 Previously, research into creating an anti-thrombogenic 
surface to line the ventricles of decellularized whole hearts has been geared towards 
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recreating an endothelium while neglecting the remaining layers of the 
endocardium.63,75,76 However, the endocardium is essential to maintaining a healthy heart 
and may play an integrate role in regulating cardiac function.12 The following research 
discussed in this paper is focused on developing a reconstituted endocardium in the 
ventricular cavities of acellular myocardium.  
 
1.4.2 Project Aims 
Aim 1: To develop and characterize an acellular rabbit myocardial scaffold through 
bi-ventricular perfusion decellularization. 
Hypothesis: Our bi-ventricular perfusion decellularization system will produce acellular 
whole rabbit hearts with preserved ventricular cavity surface structure, shape, and 
extracellular composition. 
Aim 2: To reconstitute the endocardium inside the acellular ventricular cavities 
with clinically relevant hydrogels and cell types.  
Hypothesis: Our novel seeding device, technique, and bioreactor will support hydrogel 
adherence and cellular attachment, integration, and activity on the surface of ventricular 
cavities of acellular whole rabbit hearts.  
 
1.4.3 Project Significance  
We are the first researchers to pursue tissue engineering the endocardium, as 
opposed to exploring re-endothelializing the endothelium, inside the ventricular cavities 
of decellularized myocardium. This research will bring our laboratory closer to 
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accomplishing a tissue engineered whole heart and hopefully enhance the scientific 
communities understanding of the endocardium. The following information will shed 
light on the interactions between hydrogels, cells, and acellular myocardial tissue. 
Various seeding techniques were used demonstrating the applicability of combining 
multiple techniques to develop optimal protocols for cell seeding. In general, it is our 
hope that this project will aid in the advancement of the growing field of cardiovascular 
tissue engineering and make progress towards the development of alternative treatment 
options for MI and CHF.     
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CHAPTER TWO 
DECELLULARIZATION OF WHOLE HEARTS 
 
 2.1 Introduction  
One of the most promising avenues for developing a tissue engineered whole 
heart for transplantation is combining stem/progenitor cells with a decellularized 
myocardial scaffold. Decellularized myocardial scaffolds are created by stripping native 
cells from their adhesion sites while preserving the structure and composition of the 
ECM. Using decellularized myocardium as a scaffold for cardiac tissue engineering 
presents several advantages. First, the vasculature pathways are preserved providing the 
frame work for creating blood vessels to supply nutrients to seeded stem/progenitor cells. 
One of the biggest challenges in cardiovascular tissue engineering is developing a non-
thrombogenic blood vessel or blood vessel substitute.83 This is especially true for tissue 
engineering whole organs. Similar to the limitation for cell sheeting, there is a depth limit 
for how far cells can be seeded into a scaffold and still remain viable. Once diffusion can 
no longer mediate nutrient exchange, it becomes apparent that a blood vessel or blood 
vessel substitute is needed to reach the seeded cells. Second, decellularization effectively 
eliminates all immune reacting agents. This allows for the scaffold to be implanted in the 
body without eliciting an adverse immune response like naturally derived and 
biodegradable synthetic materials. However unlike decellularized myocardium or 
naturally derived materials, biodegradable synthetic scaffolds may emit degradation 
products that cause persistent host inflammation.50 Lastly, decellularized myocardium 
presents a unique set of structural advantages by having a microenvironment, 
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composition, and architecture that resembles native myocardium.48,49 Additionally, the 
preserved architecture provides adhesion sites previously occupied by native cardiac cells 
for attaching seeded stem/progenitor cells. This tissue specific microenvironment has yet 
to be recreated using naturally derived or synthetic materials. However, effectively 
decellularizing whole organs without compromising ECM integrity is a difficult task. 
Some researchers have reported the loss of growth factors, ECM proteins, and distortion 
of scaffold architecture while using certain decellularization protocols.60  
The first successful decellularization of a whole heart was reported by Ott (2008). 
They accomplished perfusion decellularization of whole rat hearts.63 Since then, many 
researchers have reported the successful decellularization of whole hearts from several 
species.62,75–79,84–90 Each species has varying clinical relevance and practical justification. 
In our study, we choose to decellularize whole rabbit hearts. Although rabbit hearts are 
not as clinically relevant in size as porcine or cadaveric human hearts, they are more 
clinically relevant than mouse and rat hearts. Rabbit hearts come from a live source 
limiting the potential disease state that may be present unlike cadaveric human hearts. 
Less resources are required to decellularize and recellularize rabbit hearts making them 
more cost-effective than cadaveric human hearts or porcine hearts. Lastly, the 
decellularization system adapted from Jason Schulte is limited to housing only one 
cadaveric human heart or one porcine heart cannulated at the aorta. We successfully 
modified the inner-housing chamber design to fit four bi-ventricular cannulated rabbit 
hearts. This allowed us to generate a large number of replicates for statistical comparison 
while effectively decellularizing both ventricles.     
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 2.2 Methods 
2.2.1 Whole Heart Collection and Preparation 
Rabbits were beheaded, skinned, and shipped frozen on dry ice for 48 hours from 
Animal Technologies (Tyler, TX) (Figure 11A). Following euthanasia, the use of 
harvested tissue from an animal carcass is not covered by IACUC. Once the rabbit 
carcasses arrive, they are stored in a -20˚C freezer until tissue dissection. Prior to tissue 
harvesting, rabbit carcasses are thawed for 5 hours on bench top. Whole hearts are 
extracted from rabbit carcasses with careful consideration to not puncher or damage any 
of the heart’s chambers. Ample length of pulmonary trunk, aorta, inferior vena cava, 
superior vena cava, and pulmonary veins and arteries are left intact for cannulation or 
ligation. Rabbit hearts underwent three cycles of submerging and gently massaging in 30 
mM Ethylenediaminetetraacetic Acid (EDTA) to remove potential blood clots inside the 
ventricles. After washing, rabbit hearts were stored in a -20˚C freezer until the first day of 
decellularization. 
To prepare rabbit hearts for attachment to our decellularization system, each of 
the four rabbit hearts were cannulated at their aortas and the pulmonary trunks with 
barbed lures. Sutures wrapped tightly around the vessels reinforced by zip-ties secured 
the barbed lures in place. All other vessels attached to the heart were ligated by bundling 
them together and tightly lassoing a suture around them (Figure 11B).   
To acquire fresh native heart samples for a control in immunohistochemistry, a 
native rabbit heart was dissected from a fresh rabbit carcass shipped from Animal 
Technologies. The rabbit was beheaded, skinned and shipped overnight on ice. Once the 
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carcass arrived, the heart was immediately dissected from the thoracic cavity. Following 
dissection, the fresh native rabbit heart was submerged and massaged in Phosphate 
Buffered Saline (PBS) three times to remove excess blood in the chambers and 
vasculature. Fresh PBS was used all three times. We used 10% buffered formalin to store 
the fresh native rabbit heart after rinsing with PBS. The fresh native rabbit heart was left 
static in the 10% buffered formalin for 4 days until samples were acquired for 
immunohistochemistry.  
For histology and scanning electron microscopy, a fresh native rabbit heart was 
retrieved from the Godley Snell Research facility in Clemson, SC following the 
euthanasia of a control group of rabbits from an unrelated animal study. Rabbit hearts 
were dissected at the facility following rabbit euthanasia and stored in 10% buffered 
formalin. After 4 days of fixation, we collected samples from the fresh native rabbit 
heart.  
 
2.2.2 Decellularization System Set-Up 
The Decellularization System was originally adapted by Jessica Canavan from Dr. 
Schulte’s decellularization protocol for porcine myocardium.90,91 However, Jessica 
Canavan’s rabbit heart tree composed of numerous y-connectors and small diameter 
tubing has since been replaced with a circular glass manifold supported by a 3-D printed 
ABS stand (Figure 12). Currently, the decellularization system is composed of an acrylic 
housing chamber, two fluid reservoirs, a glass manifold, a 3-D printed ABS stand, and a 
multi-channel peristaltic pump (Masterflex, Cole-Parmer) (Figure 13). The circular glass 
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manifold attaches four hearts with ¼ inch inner diameter tubes at the pulmonary trunk 
and aorta to allow retrograde perfusion into each ventricle. The acrylic housing chamber 
and both fluid reservoirs are connected in series by ¼ inch inner diameter tubes. The first 
fluid reservoir was positioned 90 cm above the cannulated rabbit hearts. Gravity drives 
each decellularization solution down from the first reservoir into the circular glass 
manifold located inside the acrylic housing chamber. The hydrostatic pressure generated 
from this height difference yielded a pressure of 12.72 mmHg entering each ventricle. 
The second fluid reservoir was positioned below the acrylic housing chamber at an 
unspecified distance. The multi-channel peristaltic pump was located below the second 
fluid reservoir at an arbitrary distance from the second fluid reservoir. Gravity drives 
each decellularization solution from the acrylic housing chamber to the second fluid 
reservoir and from the second fluid reservoir to the multi-channel peristaltic pump. Fluid 
is driven upward from the multi-channel peristaltic pump back to the first fluid reservoir, 
where the process repeats itself. For every decellularization solution, 3.5L was used in the 
decellularization system.  
 
2.2.3 Decellularization Procedure  
Decellularization began by perfusing 30mM EDTA in PBS (pH 7.5) into each 
rabbit heart ventricle via the decellularization system to remove potential blood clots. The 
following day the solution was replaced with 1% w/v Sodium Dodecyl Sulfate (SDS) to 
begin removing cellular and DNA content. SDS treatment continued for a total of 20 days 
with fresh 1% w/v SDS replaced every 4 days. Afterwards, we began a series of wash 
 43 
cycles with every cycle consisting of three fresh solution changes occurring at increments 
of 4 hours, overnight, and 4 hours. For the first wash cycle we used ddi water, followed 
by 70% ethanol for the second cycle, ddi water for the third cycle, and PBS for the final 
cycle. At the conclusion of the wash cycles, we replaced the last solution with 720 
milliunits RNAse/DNAse in PBS with 5mM MgCl2 (pH 7.4). RNase/DNase treatment 
continued for 4 days with fresh solution replaced at the 2-day mark. Lastly, we began a 
final wash cycle of PBS following RNAse/DNase treatment. The PBS wash cycle was 
conducted analogous to previous wash cycles where fresh solution was replaced in 
increments of 4 hours, overnight, and 4 hours. Every solution perfused overnight 
included 0.02% sodium azide for sterility. Once the decellularization procedure was 
complete, each decellularized scaffold was removed from the circular glass manifold and 
stored at 4˚C in a PBS cocktail containing 0.02% sodium azide and 0.001% protease 
inhibitor.  
 
2.2.4 DNA Extraction and Quantification  
Native tissue was used a control for all DNA quantification. DNA was extracted 
from decellularized tissue (n=6) and native tissue (n=6) using a DNeasy® Blood & 
Tissue Kit from Qiagen (Hilden, Germany). Samples were quantified using nanodrop 
spectrometry with a reading absorbance of 260 nm. Each quantified sample was 
normalized using the respective sample wet weight measured prior to tissue digestion. 
Normalized quantities were displayed as ng/mg wet tissue.  
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Additionally, ethidium bromide agarose gel electrophoresis was used on DNA 
isolated native tissue samples (n=6) and decellularized tissue samples (n=6) for analysis. 
DNA bands were obtained using Sub-Cell® GT electrophoresis protocol and equipment 
(170-4402, BioRad, Hercules, CA) and measured in a BioRad Gel Imager using 
densitometry.  
 
2.2.5 Histology and Immunohistochemistry (IHC) 
Following formalin fixation, decellularized scaffold and fresh native rabbit hearts 
were used for sample collection. Rectangular sections along the circumferential axis were 
obtained from both ventricles and horizontal rectangular sections were obtained from the 
septum wall. An automated Sakura Tissue Tek VIP 5 Tissue Processor (2315-30-1003, 
Sakura, Torrance, CA) was used to process samples and prepare them for paraffin 
embedding. The automated process consisted of a series of steps where samples undergo 
10% buffered formalin washes, incremental dehydration from 70% ethanol to 100% 
ethanol, xylene incubation, and paraffin incubation. Upon sample retrieval from the tissue 
processor, samples were embedded in paraffin and sectioned using at microtome to 
produce 5 µm sections on glass histological and IHC slides.  
For histology, sections adhered to glass histological slides were rehydrated and 
stained for either Masson’s Trichrome for Connective Tissue or Diamidino-2-
phenylindole (DAPI) fluorescent nuclear stain. Masson’s Trichrome for Connective 
Tissue stain was conducted using the provided staining kit and protocol (k037, Poly 
Scientific R&D Corporation, Bay Shore, NY). DAPI fluorescent nuclear stain was 
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performed using a special mounting medium containing DAPI (H-1500, Vector 
Laboratories, Burlingame, CA). 
IHC began with rehydrating sections adhered to glass IHC slides. Following 
rehydration, antigen retrieval was accomplished by 10-minute exposure to 90˚C 10mM 
citric acid monohydrate (pH 6). Afterwards, IHC slides were treated with 0.025% Triton 
X-100 in two 5-minute increments. Next, IHC slides were incubated with normal 
blocking serum for 45 minutes before primary antibody administration. Mouse Anti-
Laminin (MAB1922; Millipore, Burlington, MA), Mouse Anti-Fibronectin (MAB1940; 
Millipore), and Mouse Anti-Collagen IV (Dako Agilent Pathology Solutions, Santa 
Clara, CA) primary antibodies were applied in dilutions of 1:500, 1:300, and 1:33 
respectively for either an overnight incubation in a 4˚C incubation chamber or a 1-hour 
incubation at room temperature. To obtain a negative control per IHC slide, the primary 
antibody was omitted in one of the sections. The diaminobenzidine tetrahydrochloride 
peroxidase substrate kit and R.T.U. Vectastain Kit were purchased from Vector 
Laboratories. To counterstain IHC slides, hematoxylin diluted in distilled water was 
applied for 40 seconds. Following dehydration and mounting, Zeiss Axiovert 40CFL 
microscope and AxioVision Release 4.6.3 digital maging software (Carl Zeiss 
MicroImaging, Inc., Thornwood, NY) were used to image all histological and IHC stains.   
 
2.2.6 Scanning Electron Microscopy (SEM) 
Decellularized scaffold samples and fresh native samples fixed in 10% buffered 
formalin were washed with ddH20 for 30 minutes with fresh ddH20 replaced every 10 
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minutes. Samples were treated with 1% osmium tetroxide for 1 hour to accomplish 
secondary fixation. Following secondary fixation, another wash with ddH20 lasted for 30 
minutes with fresh ddH20 replaced every 10 minutes. Increasing increments of ethanol 
from 50% to 100% was used to dehydrate samples. After dehydration, samples were 
dried using hexamethyldisilazane (HMDS) by treating them with 50/50 ethanol/HMDS 
for 15 minutes, pure HMDS for 15 minutes, and left overnight setting in pure HMDS. A 
platinum coating was applied to tissue samples and imaged using Hitachi S4800 SEM at 
Clemson University Advanced Materials and Research Facility, Anderson, SC.  
 
 2.2.7 Statistics 
Data obtained from nanodrop spectrometry was quantified by reading absorbance 
and normalized by wet weight for analysis using a student t-test. 
 
 2.3 Results  
The novelty of this decellularization system (Figure 13) is that it houses 4 rabbit 
hearts while perfusing decellularization chemicals into both ventricles simultaneously 
(Figure 12). We utilized multiple techniques to analyze the effectiveness of cellular 
removal using this system. First, the color change of burgundy in fresh native tissue to 
snow-white in decellularized tissue suggested successful decellularization (Figure 14). 
Second, DNA analysis using nanodrop spectrometry revealed a significant drop in DNA 
content from native tissue to decellularized tissue. Additionally, gel electrophoresis 
depicted a lack of DNA content in decellularized tissue samples (Figure 15). Third, 
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DAPI fluorescent nuclear stain and Masson’s Trichrome stain did not stain positive for 
nuclei in decellularized tissue samples (Figure 16). Fourth, SEM images of the 
decellularized scaffold did not reveal an endothelium on the surface of the tissue (Figure 
18) IHC stained for basal lamina components (laminin, collagen IV, and fibronectin) was 
performed for decellularized samples and native samples (Figure 17). Lack of positive 
stained regions in collagen IV and fibronectin IHC stains suggests the decellularization 
procedure caused partial disruption of the basal lamina. 
 
Figure 11: Tissue collection. (A) Rabbit carcass delivered from Animal Technologies. 
Carcass is thawed in glass tray on bench top prior to dissection. (B) Four rabbit hearts 
cannulated at the aorta and pulmonary trunk prior to decellularization. All other entering 
and exiting vessels are bundled together and ligated.  
Rabbit Heart Preparation  
B A 
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Figure 12: Decellularization manifold and stand. (A) Solidworks designs showing 
manifold and stand. (B) Representative image of decellularization fluid flowing into both 
ventricles of four rabbit hearts attached to the manifold.  
B A 
Manifold and Stand Design  
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Figure 13: Rabbit heart decellularization system. Decellularization system composed 
of, 1, two fluid reservoirs, 2, two overflow containers for reservoirs, 3, circular glass 
manifold and 3-D printed ABS stand stored inside an acrylic housing chamber, 4, multi-
channel peristaltic pump.  
Decellularization System 
1 
3 
2 
2 
1 
4 
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Figure 14: Decellularization cue by color change. Fresh native heart changes from (A) 
burgundy to (B) snow-white during decellularization.  
 
Figure 15: DNA analysis of native rabbit heart and decellularized scaffold. (A) 
Averaged DNA content from Decellularized scaffold samples and fresh native rabbit 
heart samples obtained from nanodrop spectrometry. (B) Isolated and digested DNA 
Gel Electrophoresis Nanodrop Spectrometry 
B A 
B A 
Fresh Native Heart  Decellularized Heart  
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content from decellularized scaffold and fresh native samples assessed using gel 
electrophoresis. From left to right the columns are: blank, standard, fresh native samples 
1-6, and decellularized scaffold samples 1-6. 
 
Figure 16: Histological analysis of native rabbit heart and decellularized scaffold. 
(A) DAPI fluorescent nuclear stain and (B) Masson’s Trichrome stain on native rabbit 
myocardium and decellularized scaffold. Bars are set to 100 µm. 
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Figure 17: Immunohistochemistry analysis of native rabbit heart and decellularized 
scaffold. IHC on basal lamina components: (A) Collagen IV, (B) Fibronectin, and (C) 
Laminin. Positive reactions depicted by black arrows. Negative controls displayed in 
bottom corner of each image. Bars are set to 50 µm. 
 
Figure 18: Scanning Electron Microscopy (SEM) analysis of native rabbit heart and 
decellularized scaffold. (A) Left ventricle and (R) right ventricle samples were imaged 
at 200x magnification and 1000x magnification.  
 2.4 Discussion  
2.4.1 Decellularization Indicated by Color Change 
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Images of rabbit heart before and after decellularization are shown in Figure 14. 
First, a picture was taken of fresh native rabbit heart prior to vessel cannulation and 
ligation. Then another picture was taken following the conclusion of decellularization. 
Through the decellularization process, the color of each rabbit heart progressively 
changed from burgundy to white indicating the removal of cellular content. Ott (2008) 
described a similar change in color during decellularization of rat hearts. Retrograde 
perfusion of SDS through the aorta of the rat hearts was performed for 12 hours. 
Afterwards, they reported a chamber by chamber change in color. First, both atria turned 
translucent, followed by the right ventricle, and ending with the left ventricle.63 In our 
study we used retrograde perfusion into both ventricles through the aorta and the 
pulmonary trunk (Figure 12B). However, we did not keep track of the chamber by 
chamber change of color through the progression of our decellularization procedure. We 
also used hearts from a larger species and decellularized multiple hearts at once, 
accounting for the longer duration and larger number of SDS cycles.  
 
2.4.2 Decellularization Indicated by DNA Reduction 
DNA content was assessed using nanodrop spectrometry and gel electrophoresis 
(Figure 15). Gel electrophoresis did not reveal any white bands in the decellularized 
scaffold sample columns, while white bands can be seen in both the standard and fresh 
native sample columns. White bands appearing in the sample columns are an indication 
of DNA content present in those samples. The lack of white bands found in the 
decellularized sample columns suggests the successful removal of DNA content.  
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A student’s t-test on quantified DNA content from decellularized scaffold samples 
and fresh native myocardium samples revealed a significant reduction in DNA content 
(p-value < 0.001). DNA concentration was reduced by 85.7% from 664.5 ± 128.4 ng 
DNA/mg tissue for fresh native myocardium to 95.1 ± 8.6 ng DNA/mg tissue for 
decellularized scaffold. Zhang (2015) also reported the successful decellularization of 
rabbit hearts. New Zealand white rabbit hearts were decellularized using antegrade 
perfusion of SDS for 12 hours per heart. They saw a DNA reduction from 513.6 ± 16.9 
ng DNA/mg tissue to 48.3 ± 13.4 for native myocardium to decellularized myocardium.89 
Although they reported a higher reduction in DNA concentration, we had a larger 
standard deviation associated with our quantification of native DNA content which may 
be skewing our results. More native samples will be needed to gain a more accurate 
representation of the DNA content found in the rabbit hearts we used for 
decellularization.  
 
2.4.3 Decellularization Assessment by Histology, SEM, and IHC 
Fresh native myocardium and decellularized scaffold samples were stained with 
DAPI fluorescent nuclear stain and Masson’s Trichrome stain for connective tissue 
(Figure 16). DAPI fluorescent nuclear stain did not reveal any remaining nuclei in the 
decellularized scaffold samples while a cell dense myocardium could be seen in the fresh 
native samples. Lack of fluorescing nuclei indicates the elimination of cells in the 
scaffold during decellularization. Masson’s Trichrome stain depicts collagen as blue, 
muscle fibers as red, and cells as black. In the fresh native samples, Masson’s Trichrome 
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stain revealed a dense muscle fiber environment encased in a collagen network with cells 
dispersed throughout the sample. Decellularized scaffold samples stained with Masson’s 
Trichrome stain displayed a different environment. Nuclei was not present evident by 
lack of black positive stained cells. Majority of the remaining scaffold was composed of 
collagen. Muscle fibers content was mostly eliminated with only a few regions faintly 
stained red. The structure, collagen fiber orientation, and extracellular matrix architecture 
of the decellularized scaffold was kept mostly intact. Additionally, the decellularized 
scaffold had a larger number of pores with various open compartments previously 
occupied by cells.  
Others have also used these histological stains to examine decellularized 
scaffolds. Weymann (2011, 2014) used DAPI fluorescent nuclear stain and Masson’s 
Trichrome to evaluate porcine heart scaffolds decellularized with SDS. They discovered a 
lack of nuclei depicted from DAPI fluorescent nuclear stain and verified the preservation 
of the extracellular matrix using Masson’s Trichrome.76,92 Perea-Gil (2015) used 
Masson’s Trichrome on porcine heart scaffolds decellularized by either SDS or 
hypertonic and hypotonic solutions. Masson’s Trichrome stain revealed a lack of positive 
black stained cells in the scaffolds decellularized by both procedures, indicating the 
removal of cellular content.84 
SEM images at low magnification (200x) and high magnification (1000x) of the 
endocardium of decellularized tissue did not reveal an endothelial monolayer (Figure 
18). Both ventricles of the decellularized scaffold retained similar surface structures and 
shape as native ventricles. Low magnification images revealed ridges of collagen 
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bundles. High magnification images depicted several regions with a confluent surface 
rich in available bonding sites. Other researchers have also used SEM to verify the 
removal of cellular content of decellularized heart scaffolds. Ott (2008) reported the 
removal of myofibrils in the myocardium using SEM following decellularization of rat 
hearts with SDS.63 Similarly, Carvalho (2012) decellularized rat hearts with SDS and 
used SEM to verify the removal of cellular content and preservation of the extracellular 
matrix.86   
The use of detergents to decellularize tissues has been reported to remove or 
disrupt essential extracellular matrix components in literature.60 SDS alone has been 
shown to disrupt collagen integrity and diminish glycosaminoglycan content while 
effectively removing cellular components.93 Every component of the extracellular matrix 
is crucial for maintaining a heart scaffold that mimics the native cardiac environment. 
IHC stains were conducted on the basal lamina components to assess the potential impact 
of our decellularization procedure on the basal lamina composition. We choose to assess 
the basal lamina of the scaffold’s ventricles because the basal lamina is responsible for 
attaching endothelial cells to the endocardium in native cardiac tissue. Collagen IV, 
fibronectin, and laminin are three basal lamina proteins that were chosen for evaluation 
(Figure 17). Our decellularized scaffold did not stain positive for collagen IV and 
fibronectin proteins during IHC staining. The lack of these proteins suggested the basal 
lamina is disrupted during decellularization. However, lamina stained positive on our 
decellularized scaffold implying the basal lamina was only partially disrupted.  
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 2.5 Conclusion  
Previous literature reports have used DNA quantification, histology, SEM, and 
color change to evaluate decellularization. Based on these reports, our methods are 
sufficient to assess the effectiveness of our decellularization procedure. Although our 
DNA quantification with nanodrop spectrometry only revealed an 85.7% decrease in 
DNA content, the combination of our other results revealed our decellularization 
procedure effectively eliminated cellular content. However, we also discovered our 
decellularization procedure had a negative impact on the basal lamina. Our IHC stains 
suggest the removal of collagen IV and fibronectin occurred along with the removal of 
cellular and DNA content. Despite this disadvantage, we determined the decellularization 
procedure yielded an acellular scaffold compatible with cell seeding.  
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CHAPTER THREE 
RECONSITUTION OF THE VENTRICULAR ENDOCARDIUM WITHIN 
ACELLULAR SCAFFOLDS 
 
 3.1 Introduction 
3.1.1 Background and Significance 
One of the biggest challenges in cardiac tissue engineering is developing an anti-
thrombogenic blood contacting surface for engineered tissue. Without an anti-
thrombogenic surface, the intrinsic coagulation cascade will be activated. This pathway 
will eventually lead to thrombosis and cause life endangering complications. In vivo, a 
tightly sealed endothelial monolayer covers the entire blood contacting surface of all 
cardiac tissue and vasculature. The endothelium acts to actively prevent thrombosis and 
allow nutrients and gas exchange to occur in between the gap junctions of the endothelial 
cells.  
Many researchers have attempted to recreate a monolayer of endothelial cells on 
decellularized cardiac scaffolds with limited success.63,75,76 This is an effective method to 
recreate an anti-thrombogenic surface for vasculature, however, the inner lining of the 
ventricular wall of cardiac tissue is more intricate than an endothelium. The endothelium 
is part of the multilayered endocardium. As previously mentioned, the endocardium has 
pathological consequences in the presence of many cardiac diseases and may have 
several impactful functions in cardiac performance.12–16 This makes the endocardium a 
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crucial component necessary to develop a tissue engineered whole heart. To our 
knowledge we are the first researchers to explore reconstituting the endocardium in 
acellular heart scaffolds.  
In addition to reconstituting the endocardium, we also explored recellularizing the 
endothelium of the coronary vasculature. To tissue engineer a whole heart, eventually 
every component of the heart’s structure must be recellularized and reconstituted. The 
significance in recreating the endothelium in the coronary vasculature is developing a 
network of a pathways for delivering nutrients and providing gas exchange. Currently, 
one of the biggest challenges in cardiac tissue engineering is developing vasculature for 
tissue engineered constructs.80 Similar to how the maximum thickness of cell sheeting 
cannot exceed 80µm due to the depth of nutrients and oxygen diffusion, the layers of a 
reconstituted heart wall cannot cumulatively exceed 80µm without a means to supply 
nutrients and gas exchange to the inner regions.51,73 Because the average thickness of the 
human ventricular endocardium does not exceed 20µm, it is not imperative to have a 
network of vasculature for the goal of this project.13 However, in future experiments if 
recreating the endocardium of the atria is explored, then it will be necessary to have a 
network of vasculature to keep the endocardium viable for thicknesses greater than 
80µm.   
 
3.1.2 Overview of Experimental Procedural Evolution  
Several experiments were performed on decellularized scaffold. Three 
experiments were performed for seeding human aortic endothelial cells (hAOECs) into 
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the ventricular cavities of decellularized scaffolds. Each of these experiments aimed at 
assessing the feasibility of recellularizing the endocardium using either static or 
centrifugal seeding techniques for administering cells. The first endocardium seeding 
experiment utilized static seeding. While the last two endocardium seeding experiments 
were duplicates of one another to assess the feasibility of centrifugal seeding.  
Two experiments were performed for seeding endothelial cells into the coronary 
vasculature using a gravitational seeding technique. The second coronary seeding 
experiment was performed to verify reproduceable results of the first coronary seeding 
experiment. After attempting coronary vasculature and endocardium recellularization, we 
decided to focus on improving endocardium cell seeding.  
We attempted two hydrogel experiments to gauge the feasibility of using different 
techniques for influencing collagen and fibrin hydrogels to infiltrate into the ventricular 
surface of our decellularized scaffold. The first hydrogel experiment explored 
lyophilization and static infusion as a potential route for integrating hydrogels into the 
scaffold. The second hydrogel experiment assessed a sequence of gravitational, 
centrifugal, and rotational infusion techniques as a potential route for integrating 
hydrogels into the scaffold. Afterwards, we decided to move forward with incorporating 
collagen and fibrin hydrogels infused by a combination of techniques into 
recellularization experiments focused on the endocardium. 
Three experiments were geared towards reconstituting the endocardium using a 
combination of hydrogels and cells. All three experiments included gravitational, 
centrifugal, and rotational cell seeding and hydrogel infusing techniques. The first 
 61 
experiment integrated a mixed collagen-fibrin hydrogel into the ventricular cavities 
followed by seeding a layer of hAOECs and human adipose-tissue derived stem cells 
(hADSCs, LaCell Inc, New Orleans, LA). The last two experiments utilized a layer-by-
layer tissue engineering approach for reconstituting the endocardium. The third 
endocardium reconstitution experiment did not fill in any missing information for this 
thesis and will be used to show reproducibility for a later publication. The results from 
third endocardium reconstitution experiment will be left out of this thesis and be finished 
a later date. In the second and third endocardium reconstitution experiments, collagen and 
fibrin hydrogels were infused separately along with layers of fibroblast cells 
differentiated from adipose derived stem cells and endothelial cells. A summary of each 
experiment’s methods, rationale, and outcomes can be found in Table 1.  
  
 3.2 Methods 
3.2.1 Scaffold Preparation for Recellularization and Reconstitution Experiments 
Each of the three endocardium seeding experiments, two coronary seeding 
experiments, and three endocardium reconstitution experiments began with the same 
scaffold preparations. First, the scaffold was checked for non-sutured holes or vessels 
unbound by ligation. Any holes or unbound vessels were sutured closed except for the 
aorta and pulmonary trunk. Sterile 0.1% peracetic acid was made in ddH20 and pH to 
7.4. The scaffold was incubated in 100 mL of sterile 0.1% peracetic acid at room 
temperature for 2 hours to sterilize the tissue. Sterile 1xPBS was made in ddH20 and pH 
to 7.4. Following sterilization, the scaffold was washed with 100 mL 1xPBS for three 
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hours at room temperature. Sterile 1xPBS was replaced after every hour for a total of 3 
fresh solution changes. A sterile cocktail containing half Fetal Bovine Serum (FBS) 
(Atlanta Biologicals, Flowery Branch, GA) and half Dulbecco’s Modified Eagle Medium 
(DMEM) (ThermoFisher Scientific, Waltham, MA) was made. After sterile 1xPBS 
washes, the scaffold was placed into 100 mL of sterile 50/50 FBS/DMEM and incubated 
at 37˚C overnight. Following overnight incubation, the sterile 50/50 FBS/DMEM was 
exchanged for fresh sterile 50/50 FBS/DMEM and incubated at 37˚C overnight again. 
 
3.2.2 Aseptic Cell Culture  
For all endocardium seeding experiments, coronary vasculature seeding 
experiments, and the first endocardium reconstitution experiment, hAOECs (CC-2535) 
were purchased from Lonza (Basel, Switzerland). Endothelial cells were expanded to 
passage 4 and frozen down in Dimethyl Sulfoxide (DMSO). For all endocardium seeding 
experiments and coronary vasculature seeding experiments, passage 4 hAOECs were 
thawed and expanded to passage 8 or passage 9. Endothelial cells received from Lonza 
for the first endocardium reconstitution experiment were expanded from passage 0 to 
passage 7. For the last two endocardium reconstitution experiments, hAOECs (304-05a) 
were purchased from Cell Applications (San Diego, CA) and expanded from passage 2 to 
passage 9. All three endocardium reconstitution experiments used hADSCs. For the first 
endocardium reconstitution experiment, hADSCs were expanded from passage 0 to 
passage 5. For the second and third endocardium reconstitution experiments, hADSCs 
were expanded from passage 0 to passage 5 and differentiated to fibroblast cells. 
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Transforming Growth Factor Beta-1 (TGFB-1, 100-21) was purchased from PeproTech 
(Rocky Hill, NJ) and administered to hADSCs in a concentration of 2ng TGFB-1 per mL 
of media for differentiation.94 
 
3.2.3 Endocardium Seeding Experiment Procedures  
All three endocardium recellularization experiments began by preparing and 
resuspending human aortic endothelial cells hAOECs in 2 mL of endothelial cells media 
(CC-3162, Lonza, Basel, Switzerland). Cells were counted and split into two vials 
containing 1 mL of cell suspension each. The first vial was administered into the left 
ventricle through the aorta and the second vial was administered into the right ventricle 
through the pulmonary trunk using a syringe. 
For endocardium seeding experiment 1, 8.36x105 cells were seeded into the left 
ventricle and 4.36x105 cells were seeded into the right ventricle. Both ventricles were 
sealed by suturing the aorta and pulmonary trunk closed to prevent the cell suspensions 
from escaping the ventricles. The cell seeded scaffold was placed inside a sterile p-cup 
filled with endothelial cell media and incubated at 37˚C while left static and untouched 
for 3 days. Following 3 days of incubation, the cell seeded scaffold was placed into 10% 
buffered formalin in a 10:1 ratio of formalin volume to tissue volume for 4 days until 
analysis began.     
For endocardium seeding experiment 2, 5.61x106 cells were seeded into each 
ventricle. Both ventricles were sealed by suturing the aorta and pulmonary trunk closed to 
prevent cell suspensions from escaping the ventricles. The cell seeded scaffold was 
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placed into a 50mL Bio-Reaction tube ( 229475, Cell Treat, Pepperell, MA). Media was 
filled into the Bio-Reaction tube until the brim of the cell seeded scaffold was barely 
submerged. The Bio-Reaction tube containing the cell seeded scaffold and endothelial 
cell media was centrifuged at 400G for 10 minutes. The cell seeded scaffold remained 
submerged in media inside the Bio-Reaction tube overnight incubated at 37˚C. The 
following day, endothelial cell media was exchanged for fresh media and the Bio-
Reaction tube was incubated overnight at 37˚C again. After the second overnight 
incubation period, the cell seeded scaffold was placed into 10% buffered formalin in a 
10:1 ratio of formalin volume to tissue volume for 4 days until analysis began.  
Endocardium seeding experiment 3 was conducted using the same protocol as 
the second endocardium seeding experiment except with a different cell concentration. In 
this experiment, 1.95x106 cells were seeded into the left ventricle and 2.27x106 cells were 
seeded into the right ventricle.  
 
3.2.4 Coronary Seeding Device Design  
A seeding stand and funnel was designed and 3-D printed to assist in gravitation 
seeding. The funnel was printed with digital Acrylonitrile Butadiene Styrene-2 (ABS-2) 
using Stratasys Polyjet technology on an Object Connexx350 printer. A Stratasys FDM 
360mc printer was used with ABS to print the stand. The internal tunnel of the funnel and 
selected outside regions of the stand were treated with sigmacote (SL2-25ML, Sigma-
Aldrich, ST. Louis, MO) to siliconize the surfaces. The silicon layer prevented cells and 
media from infiltrating into the porous structure of the stand and funnel. To prevent the 
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cell suspension from entering the left ventricle instead of the coronary vasculature, a 
stopcock was added in between the funnel and the scaffold’s aorta. A lure was connected 
to the stopcock and tubing was used to connect the stopcock’s lure to the funnel. An 
additional lure was connected to the other side of the stop cock and used to cannulate the 
aorta of the scaffold. The coronary seeding device coupled with a stop cock was used in 
both coronary seeding experiments. The stopcock was removed and replaced with a y-
connector and two pieces of tubing to split the flow of fluids entering the funnel to adapt 
the coronary seeding device for other experiments. This adaption was used to incorporate 
the coronary seeding device into hydrogel experiment 2 and all 3 endocardium 
reconstitution experiments. The method for adapting the coronary seeding device will be 
explained in more detail in the methods for those experiments.  
 
3.2.5 Coronary Seeding Experiment Procedures 
In coronary seeding experiment 1, 14.66x106 hAOECs were prepared, counted 
and resuspended in 1mL of media. Vybrant CFDA SE Cell Tracer Kit (V12883, 
ThermoFisher Scientific) was used to fluorescently tag the endothelial cells by following 
the provided protocol. The cell suspension was pipetted through the top siliconized 
opening of the funnel, while the stopcock was positioned closed. Once the cell 
suspension reached the top of the stopcock, the stopcock was slowly opened to allow the 
cell suspension to gradually reach the aorta. This allowed for the aortic valve to close and 
the cell suspension to reside just above the aorta as it entered the coronary vasculature. 
The seeding device, scaffold, and cell suspension was carefully moved to an incubator 
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and remained untouched for 4 hours at 37˚C to allow time for cellular adhesion to the 
scaffold’s coronary vasculature. Following incubation, the scaffold was removed from 
the seeding device and a lure cap was attached to the lure cannulating the aorta. The 
scaffold was immediately transported the Godley Snell facility in Clemson, SC. An in 
vivo imaging system (IVIS) was used to image the fluorescently tagged hAOECs adhered 
to the coronary vasculature of the scaffold. Afterwards, the scaffold was placed in 10% 
buffered formalin in a 10:1 ratio of tissue volume to formalin volume for 4 days. 
Following formalin fixation, samples of the coronary vasculature were dissected from the 
scaffold and used in histology. 
For coronary seeding experiment 2, 5.75x106 hAOECs were prepared and 
suspended in 1 mL of media. The cell suspension was pipetted through the top siliconized 
opening of the funnel, while the stopcock was position closed. Once the cell suspension 
reached the top of the stopcock, the stopcock was slowly opened to allow the cell 
suspension to gradually reach the aorta. The seeding device, scaffold, and cell suspension 
was carefully moved to an incubator and remained untouched for 4 hours at 37˚C. 
Following incubation, the scaffold was removed the seeding device and placed into 10% 
buffered formalin in a 10:1 ratio of tissue volume to formalin volume for 4 days. 
Afterwards, samples of the coronary vasculature were dissected from the scaffold and 
used in histology.    
 
3.2.6 Adaptor Plug Design  
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An acrylic chamber originally designed by Dr. Lee Sierad for housing an aortic 
root was adapted to house the decellularized scaffold. To adapt the chamber, a plug was 
developed to secure the decellularized scaffold at the bottom of the chamber. The plug 
was designed to limit the available open space surrounding the decellularized scaffold to 
limit the movement of the scaffold as the chamber rotated. Holes were strategically 
placed in the plug to allow media follow between the decellularized scaffold and the rest 
of the chamber. ABS was used to 3-D print the adaptor plug on a Stratasys FDM 360mc 
printer. The plug was treated with acetone to seal external pores. A metal ring originally 
designed by Dr. Lee Sierad for securing an aortic root in the chamber was used to fill the 
space between the lid of the chamber and the plug. By filling this space, the metal ring 
kept the adaptor plug in place to assist in securing the decellularized scaffold. The 
adaptor plug was used in hydrogel experiment 2 and endocardium reconstitution 
experiment 1. 
 
3.2.7 Hydrogel Infusion Experiment Procedures  
In hydrogel experiment 1, 8 circular samples were cut from decellularized 
scaffolds. Four of the samples underwent lyophilization and four remained untreated. 
Following lyophilization, 3 lyophilized samples and 3 wet samples were placed into a 6-
well plate. One lyophilized sample and one wet sample did not receive hydrogel 
administration to be kept as negative controls. The collagen portion of the hydrogel was 
made using PureCol (5005-100ML, Advanced BioMatrix, San Diego, CA) and 
neutralized using sodium hydroxide. The fibrin portion of the hydrogel was made using 
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fibrinogen from bovine plasma (9001-32-5, Sigma-Aldrich), thrombin from human 
plasma (9002-04-4, Sigma-Aldrich), and calcium chloride. Both hydrogels were mixed 
together prior to either hydrogel solidifying. The final mixture yielded a collagen-fibrin 
hydrogel composed of 1.15625 mg/mL fibrinogen, 0.592 mg/mL collagen, 0.0765 
units/mL thrombin, and 2mM CaCl2 in 1xPBS. Once the final hydrogel mixture was 
prepared, 200 µL was pipetted over the top of each lyophilized and wet sample in the 6-
well plate. DMEM was pipetted around the wet samples such that DMEM reached the 
brim of each sample. The 6-well plate was moved to an incubator and kept untouched at 
37˚C for 48 hours. After the 48-hour waiting period, DMEM was removed from the wet 
tissue sample wells and 10 % buffered formalin was filled into every well of the 6-well 
plate. The wells were large enough to allow a 10:1 formalin volume to tissue volume 
ratio. Samples were fixed in the formalin for 4 days before analysis. 
In hydrogel experiment 2, a decellularized scaffold was checked for non-sutured 
holes or vessels unbound by ligation. Any holes or unbound vessels were sutured closed 
except for the aorta and pulmonary trunk. Lures from decellularization remained 
cannulated in the aorta and pulmonary trunk. The scaffold was washed with 1xPBS three 
times for one hour per wash to remove any remnants of the storage solution. The seeding 
stand and funnel was prepared similar to coronary seeding experiments. A small piece of 
tubing was attached to the funnel, followed by a y-connector, and two similar lengths of 
tubing was connected to each branch of the y-connector. The lure cannulating the aorta of 
the scaffold was attached to one of the similar length pieces of tubing and the lure 
cannulating the pulmonary trunk of the scaffold was attached to the other similar length 
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piece of tubing. This allowed any fluid flowing from the funnel to be split and poured 
into both ventricles of the scaffold at the same time. A mixed collagen-fibrin hydrogel 
was prepared using the same components as before. However, this time the thrombin was 
not mixed with the hydrogel mixture. The mixed hydrogel concentration was 1.2614 
mg/mL fibrinogen, 1.248 mg/mL collagen, and 2 mM CaCl2 in 1xPBS. The hydrogel 
solution was pipetted through the top of the funnel filling both ventricles of the scaffold 
simultaneously.  
The scaffold was removed from the stand and lure screw caps was placed on top 
of both lures to seal the hydrogel mixture inside of the ventricles. An acrylic chamber and 
acrylic chamber lid originally designed for an aortic root was used in combination with 
the designed plug adaptor and a metal ring to house the scaffold. The chamber was 
attached to an end-over-end rotator system and LabVIEW (National Instruments, Austin, 
TX) was used to control speed, duration, and cycles of the rotator. The decellularized 
scaffold was rotated for 15 minutes at 5 rpm on bench top. Following rotation, the 
decellularized scaffold was removed from the chamber and placed into a 250mL wide 
mouth conical tube. Additional hydrogel solution of the same composition as filled into 
the scaffold’s ventricles was poured around the scaffold to the brim of the highest portion 
of the scaffold in the conical tube. The conical tube containing the scaffold was 
centrifuged at 500G for 15 minutes at 4˚C. Following centrifugation, the scaffold was 
removed from the conical tube and excess hydrogel mixture was poured out from the 
ventricles.  
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The scaffold was then placed back onto the stand and funnel by connecting the 
lures of the pulmonary trunk and aorta to the two similar length pieces of tubing. A 
0.15708 units/mL thrombin in 1xPBS solution was pipetted through the top of the funnel 
filling both ventricles of the scaffold simultaneously. The scaffold was detached from the 
stand and funnel. Lure screw caps was attached to the lures cannulating the vessels to seal 
the thrombin solution inside the ventricles and the scaffold was placed back into the 
wide-mouth 250 mL conical tube. Thrombin solution of the same composition as filled 
into the ventricles of the scaffold was poured around the scaffold up to the brim of the 
highest portion of the scaffold in the conical tube. The conical tube containing the 
scaffold was centrifuged at 500G for 15 minutes. Following centrifugation, excess 
thrombin solution was poured from the ventricles of the scaffold. The scaffold was placed 
back into the chamber and the adaptor plug and metal ring was used to secure the scaffold 
at the bottom of the chamber. The chamber was filled with 1xPBS. Afterwards, the 
chamber was re-attached to the end-over-end rotator and rotated for 48 hours at 1 RPM 
on bench top. Following the 48-hour rotation period, the scaffold was removed from the 
chamber and fixed in 10% buffered formalin in a 10:1 formalin volume to tissue volume 
ratio for 4 days before analysis.  
 
3.2.8 Bioreactor Design  
A bioreactor was designed and manufactured for rotating and incubating the cell 
seeded scaffold for the second and third endocardium reconstitution experiments. The 
bioreactor was composed of four components. Two of the components were a pyramidal 
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cage and lid designed to secure the scaffold near the center of the chamber. The cage and 
lid was 3-D printed using ABS on a Stratasys FDM 360mc printer. Prior to use, the cage 
and lid was treated with acetone to seal all external pores. The other two components of 
the bioreactor were an acrylic chamber and acrylic chamber lid machined and polished 
for transparency. The acrylic chamber housed the scaffold secured in the pyramidal cage 
and lid. To account for a large number of cells seeded into the scaffold, the acrylic 
chamber was designed to hold roughly 500 mL of media. Three threaded holes were 
positioned on the acrylic chamber lid for the attachment of three sterile filters to allow 
gas exchange. The acrylic chamber lid is held in place by a combination of an O-ring seal 
and screws. Sterile gauze was used to line the inside of the pyramidal cage and lid to 
cushion and assist in securing the scaffold.  
 
3.2.9 Endocardium Reconstitution Experiment Procedures 
For endocardium reconstitution experiment 1, two decellularized scaffolds 
were used at the same time. Both scaffolds underwent the same experimental procedure 
with one scaffold going through each step of the procedure directly after the first 
scaffold. The scaffolds were attached to the seeding stand and funnel in the same fashion 
as the scaffold used in the second hydrogel infusion experiment. Lures left over from the 
decellularization procedure remained cannulated in the aortas and pulmonary trunks of 
the decellularized scaffolds. The lures cannulated in the aorta and pulmonary trunk were 
attached to the two similar length pieces of tubing such that fluid flowing from the funnel 
would spilt and simultaneously fill both ventricles of the attached scaffold. A hydrogel 
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mixture was prepared using the same components as the hydrogel mixture used in the 
hydrogel infusion experiments. The final composition of the hydrogel solution was 
1.2614 mg/mL fibrinogen, 1.248 mg/mL collagen, and 2 mM CaCl2 in 1xPBS.  
After the first scaffold was attached to the stand and funnel, the hydrogel solution 
was pipetted through the top of the funnel, filling both ventricles simultaneously. The 
first scaffold was removed and lure screw caps were attached to the cannulation lures to 
seal the hydrogel mixture inside the ventricles. After this step was repeated with the 
second scaffold, both scaffolds were placed into acrylic chambers with acrylic chamber 
lids originally designed for aortic roots. Two plug adaptors and metal rings were used to 
secure both scaffolds in their chambers. The chambers were attached to the end-over-end 
metal rotator used in the hydrogel experiments. LabVIEW was used to control the speed, 
duration, and number of rotation cycles. The chambers were rotated at 5 rpm for 15 
minutes on bench top. Afterwards, the scaffolds were removed from the chambers and 
placed into separate 250mL wide-mouth conical tubes. The conical tubes were 
centrifuged for 15 minutes at 500G at 4˚C. Following centrifugation, excess hydrogel 
mixture was poured out of the ventricles of the scaffolds. Two cell lines, hAOECs and 
hADSCs, were prepared, counted, and both cell lines were suspended together in 1xPBS 
supplemented with 0.15708 units/mL thrombin. The ratio of cells in the cell suspension 
was 114:1 hAOECs:hADSCs with 143x106 hAOECS and 1.25x106 hADSCs. Once the 
cell suspension was prepared, it was split into two with one aliquot per scaffold.  
The first scaffold was re-attached to the stand and funnel. One of the cell 
suspension aliquots was pipetted into the top of the funnel, filling both ventricles of the 
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first scaffold simultaneously. The first scaffold was removed and screw lure caps was 
used to seal the cell suspension inside the ventricles. After these steps were repeated for 
the second scaffold, both scaffolds were placed back into separate 250 mL wide-mouth 
conical tubes and centrifuged at 500G at room temperature for 15 minutes. Following 
centrifugation, the scaffolds were removed from the conical tubes and excess cell 
suspension was poured out of the ventricles. Both scaffolds were placed into separate 
chambers originally designed for aortic roots. Adapter plugs and metal rings were used to 
secure the scaffolds at the bottom of the chambers. A mixture of half stromal media 
(LaCell Inc.) and half endothelial cell media was used to fill the chambers. Both 
chambers were attached to the end-over-end rotator and rotated for 1 rpm for 48 hours 
inside an incubator at 37˚C.  
Following the 48-hour rotation period, two cell lines, hAOECs and hADSCs, 
were prepared, counted, and then suspended together in endothelial cell media. The ratio 
of cells in the cell suspension was 144:1 hAOECs:hADSCs with 260.4x106 hAOECS and 
2.284x106 hADSCs. Once the cell suspension was prepared, it was split into two with one 
aliquot per scaffold. Both scaffolds were removed from the chambers and the first 
scaffold was attached to the stand and funnel. One of the cell suspension aliquots was 
pipetted through the top of the funnel such that both ventricles of the scaffold filled 
simultaneously. The first scaffold was removed and lure screw caps were used to seal the 
cell suspension inside the ventricles. After these steps were completed for the second 
scaffold, both scaffolds were placed back into separate chambers. The media in both 
chambers were replaced with fresh 50/50 stromal media/endothelial media. Adapter plugs 
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and metal rings were used to secure the scaffolds at the bottom of the chambers. Both 
chambers were re-attached to the end-over-end rotator and rotated for 4 days at 1 rpm. 
Fresh media was replaced in both chambers as needed when indicated by visible media 
color change. After 4 days of rotating both scaffolds were fixed in 10% buffered formalin 
for 4 days in a 10:1 formalin volume to tissue volume ratio.  
Endocardium reconstitution experiment 2 and 3 were performed identical to 
one another with the same cell concentrations to show the results are reproduceable. To 
begin these experiments, the decellularized scaffold was attached to the seeding funnel 
and stand. The aorta and pulmonary trunk of the scaffold were still cannulated with lures 
from decellularization. Tubing and a y-connector were used to split the flow from the 
funnel as previously stated in the first endocardium reconstitution experimental 
procedure.  
The application of the first layer of the layer-by-layer technique began with a 
collagen hydrogel solution. The collagen hydrogel was prepared using the same 
components as previously stated in the hydrogel infusion experimental procedures with a 
concentration of 2.5 mg/mL. The collagen hydrogel solution was pipetted through the top 
of the funnel, filling both ventricles of the scaffold simultaneously. Afterwards, the 
scaffold was removed from the funnel and stand. Lure screw caps were used with the 
cannulation lures to seal the collagen hydrogel solution inside the ventricles of the 
scaffold. The scaffold was placed into the assembled bioreactor. The bioreactor was filled 
with sterile ice to prevent the collagen hydrogel from prematurely solidifying. 
Afterwards, the bioreactor was attached to the end-over-end rotator and rotated on bench 
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top for 15 minutes at 5 rpm. Following rotation, the sterile ice was emptied from the 
bioreactor and the scaffold was placed into a 250mL wide-mouth conical tube. The 
conical tube was centrifuged for 15 mins at 4˚C and 500G. After centrifugation, excess 
collagen hydrogel solution was emptied from the ventricles prior to hydrogel 
solidification. The scaffold was placed into a sterile p-cup and left untouched in an 
incubator for 30 mins at 37˚C while the infused collagen hydrogel solidified. Meanwhile 
fibroblast differentiated from hADSCs were prepared, counted, and suspended in DMEM 
with 5% FBS 1% Antibiotic-Antimycotic (AB-AM, MT30004CI, Fisher Scientific). 
Following the incubation period, the scaffold was re-attached to the stand and funnel. A 
total of 13.4x106 fibroblast cells suspended in media were pipetted through the top of the 
funnel filling both ventricles simultaneously. Afterwards, the scaffold was removed from 
the stand and funnel and the ventricles were sealed off with the lure screw caps. The 
scaffold was placed back into the assembled bioreactor. The bioreactor was filled with 
DMEM 5%FBS 1% AB-AM. Once the bioreactor was filled and reassembled, the end-
over-end rotator was placed into an incubator and the bioreactor was attached. The 
bioreactor rotated overnight at 1rpm and 37˚C. 
Following the overnight rotation in the incubator the scaffold was removed from 
the bioreactor and attached to the stand and funnel. The last addition of the first layer of 
the layer-by-layer technique was the application of an additional collagen hydrogel 
solution. The collagen hydrogel solution was prepared with the same components and the 
same concentration as before. Once prepared, the collagen hydrogel solution was pipetted 
through the top of the funnel, filling both ventricles of the scaffold simultaneously. The 
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scaffold was left untouched for a minute to allow the collagen hydrogel solution to briefly 
soak into the ventricles. Afterwards, the excess collagen hydrogel solution was poured 
from the ventricles. Lure screw caps were used to seal off the ventricles and the scaffold 
was placed back into the assembled bioreactor. The bioreactor was placed into an 
incubator and allowed to set untouched for 30 minutes at 37˚C while the remaining 
collagen hydrogel solution solidified. Meanwhile, a 3.4 mg/mL fibrinogen solution was 
prepared in ddH2O. After the incubation period, the scaffold was removed from the 
bioreactor and re-attached to the funnel and stand.  
The application of the second layer of the layer-by-layer technique began with the 
addition of the fibrinogen solution. The fibrinogen was pipetted through the top of the 
funnel, filling both ventricles of the scaffold simultaneously. Afterwards, the scaffold was 
removed from the funnel and stand and the ventricles were sealed with lure screw caps. 
The scaffold was placed back into the assembled bioreactor and re-attached to the end-
over-end rotator. On bench top, the bioreactor was rotated for 15 minutes at 5 rpm. 
Following rotation, the scaffold was removed from the bioreactor and placed into a 
250mL wide-mouth conical tube. The conical tube was centrifuged at 500G and room 
temperature for 15 minutes. After centrifugation, the scaffold was removed from the 
conical tube and excess fibrinogen solution was poured from the ventricles. A thrombin 
solution containing 0.15708 units/mL thrombin and 2mM CaCl2 suspended in DMEM 
with 5% FBS 1% AB-AM was prepared. The scaffold was re-attached to the funnel and 
stand and the thrombin CaCl2 solution was pipetted through the top of the funnel, filling 
both ventricles simultaneously. Then the scaffold was removed from the funnel and stand 
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and both ventricles were sealed using lure screw caps. The scaffold was placed back into 
the assembled bioreactor and left in an incubator untouched overnight at 37˚C.  
Following overnight incubation, hAOECs were prepared, counted, and suspended 
in endothelial cell media (211K-500, Cell Applications). A total of 161.75x106 
endothelial cells were suspended in the cell suspension. The scaffold was removed from 
the bioreactor and excess thrombin CaCl2 solution was poured from the ventricle. 
Afterwards, the scaffold was attached to the stand and funnel and the endothelial cell 
suspension was pipetted through the top of the funnel, simultaneously filling both 
ventricles of the scaffold. The scaffold was removed from the stand and funnel and the 
ventricles were sealed using lure screw caps. This step concluded the last addition for the 
second layer of the layer-by-layer technique. Once the ventricles were sealed, the scaffold 
was placed back into the bioreactor. Media was removed from the bioreactor and 
replaced with 50/50 endothelial cell media/DMEM with 5% FBS 1% AB-AM. The 
bioreactor was re-attached to the end-over-end rotator and rotated in an incubator at 1 
rpm and 37˚C overnight.  
The following day, the scaffold was removed from the bioreactor and excess 
endothelial cell suspension was poured from the ventricles. Afterwards, the scaffold was 
placed back into the assembled bioreactor. Cell media in the bioreactor was exchanged 
for fresh cell media of the same mixture and concentration. The bioreactor was re-
attached to the end-over-end rotator and rotated in an incubator at 1 rpm and 37˚C for 
three days. Cell media was replaced with fresh cell media of the same mixture and 
concentration once a day and sterile filters were replaced as needed. Following the three 
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days of rotation, the scaffold was removed from the bioreactor and fixed in 10% buffered 
formalin in a 10:1 formalin volume to tissue volume ratio. Fixation occurred for 4 days 
before analysis began. 
 
3.2.10 Histology and IHC 
Following formalin fixation, samples were obtained from every experiment for 
histology. For the first endocardium seeding experiment, circular samples were cut form 
the ventricles and used for histology. For the first hydrogel experiment, circular samples 
were cut from the scaffold prior to the experiment. Afterwards, those samples were used 
for histology. In all other experiments rectangular samples were cut from the hydrogel 
infused or cell seeded scaffolds and used for histology. In all experiments, except for the 
second hydrogel experiment, the samples were orientated along the ventricular 
circumferential axis during embedding. This provided sections with visible endocardium, 
myocardium, and epicardium. For the second hydrogel experiment, left ventricle and 
right ventricle samples were orientated in one of two ways while embedding. The first 
way was along the ventricular circumferential axis analogous to all other experiments. 
The second way was along the ventricular perpendicular axis. This provided sections 
where only the myocardium was visible. Septum samples from the second hydrogel 
experiment were only oriented along the ventricular circumferential axis. In all 
experiments, the same protocol was used for processing the tissue samples, dehydration, 
sectioning, and rehydration, as previously described in the histology section of chapter 2.  
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The histology conducted for the first endocardium recellularization experiment 
was DAPI fluorescent nuclear stain, Hematoxylin and Eosin (H&E) stain, and Alcian 
Blue stain. DAPI fluorescent nuclear stain was performed using the same protocol as 
described in the histology section of chapter 2. For H&E stain, histological slides were 
rehydrated to distilled water, exposed to hematoxylin for 10 minutes, rinsed with tap 
water, and dipped 6 times in clarifier. Then the histological slides were rinsed with tap 
water, exposed to bluing reagent for 1 minute, rinsed in tap water for 1 minute, dipped in 
95% ethanol 10 times, and placed in Eosin for 45 seconds. Afterwards, the histological 
slides were dehydrated in an ethanol gradient, dipped 10 times in xylene, placed in xylene 
for 5 minutes, mounted with mounting media, and covered with coverslips.  For Alcian 
Blue stain, histological slides were rehydrated to distilled water, mordanted in 3% acetic 
acid for 3 minutes, exposed to 1% Alcian Blue in 3% acetic acid (pH 2.5) for 30 minutes, 
and rinsed in running water for 10 minutes. Afterwards, the histological slides were 
rinsed in distilled water, counter-stained in 0.1% nuclear fast red in distilled water for 5 
minutes, and washed in running water for 1 minute. Then the histological slides were 
dehydrated in an ethanol gradient, mounted with mounting medium, and covered with 
coverslips.  
The histology conducted in all other experiments were DAPI fluorescent nuclear 
stain and Masson’s Trichrome stain. Both histology stains were performed according to 
the protocols described in the histology section of chapter 2. For the second and third 
endocardium reconstitution experiments IHC was performed staining for laminin 
proteins. The protocol used for this IHC stain was the same protocol as described in the 
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histology section of chapter 2. The microscope and imaging software described in the 
histology section of chapter 2 remained the same for imaging all experiments depicted in 
this chapter. 
 
3.2.11 DAPI Quantification Using Image J 
For the third endocardium seeding experiment, second coronary seeding 
experiment, and first two endocardium reconstitution experiments, the images obtained 
from DAPI stained histological slides were quantified using Image J (National Institutes 
of Health, Bethesda, MD). First, one section was chosen per histological slide of each 
sample. This section was imaged in 10x magnification. The entire section was imaged 
with careful regard not to duplicate any areas of the section on the images.  
Every image was subject to the following procedure. In Image J, the contrast 
setting was moved to the highest setting. Brightness was adjusted differently for each 
image such that the fluorescing nuclei are present but the background and scaffold are no 
longer yielding false positives in the image. Due to variability in lighting when imaging 
the sections, the same brightness setting could not remain constant without skewing the 
data. Once the brightness and contrast settings were adjusted, the images were made 
binary and analyzed for particles. Image J provided a particle count. This particle count 
was recorded for every image and summed together for each section. Particle counts were 
normalized by the area of the sample. Using 2.5x magnification and white light, the 
previously imaged sections were imaged again with careful regard not to duplicate any 
areas of the section on the images. The scale bar for 2.5x magnification was measured to 
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be 202.66667 pixels per 500 µm. This conversion was used for every image. Once the 
scale was adjusted, the freehand tool of image J was used to trace the outline of the 
samples present on every image. Image J provided the area of each traced outline. 
Particle counts were normalized by diving the summed particle count of the section by 
the summed area of the section, yielding units of cells/mm2. The data obtained for each 
sample was averaged with other samples obtained from the same ventricle to calculate a 
left and right ventricular average for each experiment.  
To compare these normalized particle counts to a positive control, fresh native 
samples were also analyzed using a similar approach. Native sections were assumed to be 
homogenous in cell density within the heart wall. Two samples from each ventricle, one 
sample from each coronary artery branch, and one sample from the coronary sinus were 
obtained and put through the same histological process as described above. All native 
histological slides were stained with DAPI fluorescent nuclear stain. One section was 
chosen per histology slide and six images were obtained without duplicating areas across 
images. Each region imaged was carefully selected such that there was no void space in 
any image. The scale bar for 10x magnification was measured to be 154.6667 pixels per 
100 µm. The size of the image was measured in pixels and converted to micrometers. 
Particles were counted using the same method as described above and normalized using 
the area of the image, yielding units of cells/mm2. The data obtained from each image 
was averaged with other images from the same sample to yield sample averages. Samples 
averages from the same ventricle were averaged to yield a left and right ventricular 
average.  
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To obtain a ventricular seeding efficiently for each ventricle to represent the 
percentage of cells seeded back into the decellularized heart wall, the following equation 
was used: 100 – (((native ventricle average – experiment ventricle average)/(native 
ventricle average))*100).  
 
3.2.12 Trichrome Quantification Using Image J 
For the second hydrogel infusion experiment and the second endocardium 
reconstitution experiment, the images obtained from Masson’s Trichrome stained 
histology slides were quantified with Image J. First, one section was chosen per 
histological slide of each sample. This section was imaged in 2.5x magnification. The 
entire section was imaged with careful regard not to duplicate any areas of the section on 
the images. 
Every image was subject to the following procedure. In Image J, the freehand tool 
was used to trace the outline of the section. The scale was adjusted such that 202.6667 
pixels was equivalent to 500 µm. Afterwards, the traced outline was measured to 
calculate an area of the section in µm2. Four image duplicates were made using the traced 
outline. This ensured the duplicates would have a minimum of free space surrounding the 
sections to limit false positives. The first duplicate was measured for the first half of the 
red content present in the image. In image J, the color threshold was adjusted in HSB. 
The Hue range was changed to 0-13. The saturation range was adjusted to be close to end 
of the provided curve such that red content was fluorescing while the background content 
did not contain visible false positives. This saturation range changes from section to 
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section. To stay consistent per image, the saturation range was recorded and kept constant 
for each duplicate of an original image. Brightness range was adjusted to the absolute end 
of the provided curve. The brightness range also changes from section to section. 
However, the brightness range was recorded and kept constant for each duplicate of an 
original image. The duplicate image’s brightness and contrast where both raised to the 
highest provided value. Afterwards, the duplicate image was made binary and analyzed 
for particles. Instead of recording the total particles, the total area of all particles 
combined was recorded.  
For the second duplicate image, the same procedure for the first duplicate image 
was followed with one exception. The second half of the red content was measured by 
adjusting the hue range to 232-255. The third duplicate image was used to measure the 
amount of blue content. To accomplish this, the same protocol was used as the first two 
duplicate images with one exception. The hue range was adjusted to 151-187. 
The fourth duplicate image followed a different protocol. All color except white 
was measured in this duplicate image. An area of all color except white resulted in the all 
the tissue in the image fluorescing. By subtracting the total area obtained from the traced 
outline and the measured area of all color except white, we could calculate a value 
representative of the pore area of the section imaged. To obtain a measurement of all 
color except white, we adjusted the color threshold in RGB. Green and blue ranges were 
both set to 0-255. Red range varied from image to image. We adjusted the red range to be 
0-X, such that ‘X’ was the value that yielded the most scaffold fluorescing without 
having white false positives in the background.  
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For each section, all like-values across the images of a section where summed 
together. Percentages of the amount of fibrin area, pore area, and collagen area in each 
section were calculated. The first half of the red content and the second half of the red 
content were added together. This new value of total red content was divided by the value 
found for all color except white. This ratio was multiplied by 100 to yield the fibrin 
percent of the section.  To calculate collagen percent, the blue content was divided by the 
value found for all color except white. Afterwards, this ratio was multiplied by 100. 
Percentages for the pore area of the sections were calculated by the following equation: 
((Traced outline area – All color area except white)/(Traced outline area))*100. Samples 
of the same ventricle were averaged together to obtain ventricular averages. A negative 
control was obtained by applying the same procedure to untreated decellularized scaffold 
histological slides stained with Masson’s Trichrome stain.  
 
3.2.13 Statistics 
Data obtained from Image J quantification of histology was averaged for samples 
from the same ventricle and standard deviations were calculated for each average. A 
student t-test was used for several comparisons. The first student t-test was used in the 
second hydrogel experiment to compare decellularized samples with hydrogel infused 
samples where each compared data set kept orientation and ventricle constant. Another 
student t-test compared cell seeded samples from the second endocardium reconstitution 
experiment with hydrogel infused samples of the same orientation and ventricle from the 
second hydrogel experiment. Lastly, an additional student t-test compared cell seeded 
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samples from the second endocardium reconstitution experiment with decellularized 
samples of the same orientation and ventricle from the second hydrogel experiment. JMP 
(SAS, Cary, NC) was used to perform an in-depth statistical analysis using ANOVA on 
data generated by Image J quantification of Masson’s Trichrome stain. P-values 
representing the significance of each factor were generated by JMP for summaries across 
multiple data types (collagen percent, fibrin percent, and pore percent) from the same 
experiment. Significant factors (p-value < 0.05) were further analyzed in JMP with 
individual ANOVA tables for each data type and linear contrasts.  
Table 1: List of Experiments 
Experiment  Rationale Methods Outcomes  
Endocardium 
Seeding 
Experiment 1 
Evaluate cellular 
adhesion and 
viability on 
scaffold surface. 
Static cell seeding  Scaffold supports 
viability and cellular 
attachment.   
Endocardium 
Seeding 
Experiment 2 
Evaluate cellular 
adhesion and 
infiltration in 
scaffold 
subendothelium. 
Centrifugal cell seeding Cells can infiltrate 
subendothelium 
through surface pores. 
Improved adhesion 
compared to static 
seeding beneath the 
acellular ventricular 
surface. 
Endocardium 
Seeding 
Verify 
reproducible 
Centrifugal cell seeding Verified reproducible 
results from 
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Experiment 3 results from 
Endocardium 
Seeding 
Experiment 2 and 
determine cell 
distribution inside 
both ventricles. 
Endocardium Seeding 
Experiment 2. 
Centrifugal seeding 
yielded poor cell 
distribution.  
Coronary 
Seeding 
Experiment 1 
Evaluate feasibility 
of seeding 
technique for 
infiltrating cells 
into coronary 
vasculature. 
Gravitational cell 
seeding through seeding 
device and stop cock, 
immunofluorescence 
Seeding technique 
supports infiltration in 
large vessels. Poor 
results in small 
vessels. 
Coronary 
Seeding 
Experiment 2 
Verify 
reproducible 
histological results 
from Coronary 
Seeding 
Experiment 1 and 
determine cell 
distribution in 
large coronary 
vessels. 
Gravitational cell 
seeding through stop 
cock 
Verified reproducible 
results from Coronary 
Seeding Experiment 1. 
Cells accumulated 
most in the coronary 
sinus. Right and 
circumflex coronary 
arteries had similar 
seeding efficiencies.  
Hydrogel 
Experiment 1 
Evaluate 
lyophilization 
influence on 
hydrogel infusion. 
Lyophilization versus 
wet tissue in static 
hydrogel infusion   
Lyophilization does 
not allow for more 
hydrogel infusion 
beneath the ventricular 
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surface.  
Hydrogel 
Experiment 2 
Evaluate hydrogel 
infiltration into 
scaffold’s pores, 
distribution of 
hydrogel inside 
scaffold’s 
ventricles, and 
hydrogel adhesion 
on scaffold’s 
surface. 
Gravitational, 
centrifugal, and 
rotational hydrogel 
infusion. Samples 
embedded into paraffin 
along circumferential 
axis or along 
perpendicular axis. 
Hydrogel infiltrates 
into perpendicular 
pores better than 
circumferential pores. 
Hydrogel distributes 
well along 
perpendicular axis but 
not along 
circumferential axis. 
Poor adhesion to 
surface. 
Endocardium 
Reconstitution 
Experiment 1 
Evaluate cellular 
adhesion and 
distribution on 
scaffold surface 
after using this 
combination of 
seeding 
techniques. 
Gravitational, 
centrifugal, and 
rotational cell seeding 
and hydrogel infusion 
Combined techniques 
improve cellular 
adhesion compared to 
previous experiments. 
Improved cellular 
distribution in right 
ventricle.   
Endocardium 
Reconstitution 
Experiment 2 
Evaluate cellular 
adhesion, 
distribution, and 
activity on scaffold 
surface using a 
layer-by-layer 
tissue engineering 
Layer-by-layer tissue 
engineering using 
gravitational, 
centrifugal, and 
rotational cell seeding 
and hydrogel infusion 
Patches of 
reconstituted 
endocardium adhered 
to ventricular surface. 
Cellular distribution 
and adhesion similar 
to endocardium 
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approach. Evaluate 
hydrogel adhesion 
and distribution 
inside scaffold’s 
ventricles. 
reconstitution 
experiment 1. 
Improved hydrogel 
distribution and 
adhesion to ventricle 
surface compared to 
the second hydrogel 
experiment. Hydrogel 
supports cellular 
activity.   
Endocardium 
Reconstitution 
Experiment 3 
Reproducible 
results from 
Endocardium 
Reconstitution 
Experiment 2 for a 
later publication.  
Layer-by-layer tissue 
engineering using 
gravitational, 
centrifugal, and 
rotational cell seeding 
and hydrogel infusion 
Experiment results are 
in progress.  
 
 3.3 Results 
3.3.1 Endocardium Seeding Experiments 
Static seeding used in endocardium seeding experiment 1 resulted in cells 
attaching on the surface of the ventricular cavities and in the subendothelium (Figure 
18). DAPI fluorescent nuclear stain, H&E stain, and Alcian Blue stain all confirmed these 
findings and were consistent with one another. Centrifugal seeding using in 
endocardium seeding experiments 2 and 3 influenced cells to adhere to the 
subendothelium beneath the surface (Figure 19). However, some of the cells were unable 
to penetrate the surface and instead attached along the inner lining of the ventricular 
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cavities. Nuclei quantification by Image J from DAPI fluorescent nuclear stain images of 
endocardium seeding experiment 3 revealed a large variation amongst samples from 
the same ventricle (Table 3). The seeding efficiency of endocardium seeding 
experiment 3 was 0.099% of cells re-seeded into the left ventricle heart wall and 0.113% 
of cells re-seeded into the right ventricle heart wall (Table 2,3).  
 
Figure 19: Endocardium seeding experiment 1 histological analysis of native heart 
and cell seeded scaffold. (A) DAPI fluorescent nuclear stain, (B) Hematoxylin and Eosin 
(H&E) stain, and (C) Alcian Blue stain on native rabbit heart and cell-seeded scaffold. 
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Bars are set to 100 µm. Red and black arrows depict cells seeded within the ventricular 
cavities.  
 
Figure 20: Endocardium seeding experiments 2 and 3 histological analysis of native 
heart, decellularized scaffold, and cell seeded scaffold.  (A) Native rabbit 
endocardium, (B) decellularized scaffold and (C) cell-seeded scaffold stained with DAPI 
fluorescent nuclear stain and Masson’s Trichrome stain. Bars are set to 100 µm. Red and 
black arrows depict cells seeded within the pores of the scaffold. Native left ventricle and 
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scaffold right ventricle DAPI fluorescent nuclear stain images were shown previously in 
Figure 16 in chapter 2. These images are shown again for comparison.  
 
Table 2: Native Heart Nuclei Quantified by Image J for Ventricles 
Sample Image 
Cell 
Count 
Area 
(mm2) 
Cells per Area 
Averaged for Sample 
(Cell Count/mm^2) 
Cells per Area Averaged 
for Ventricle (Cell 
Count/mm^2) 
Cells per Area 
Standard Deviation for 
Ventricle 
Right 
Ventricle 
Sample 
1 
1 1003 
0.569 
1953.0 
1942.6 293.6 
2 1026 
3 1326 
4 1223 
5 950 
6 1143 
Right 
Ventricle 
Sample 
2 
1 1159 
1932.2 
2 1428 
3 1182 
4 925 
5 880 
6 1026 
Left 
Ventricle 
Sample 
1 
1 1469 
2121.6 
1929.0 367.7 
2 1321 
3 1242 
4 1093 
5 1101 
6 1021 
Left 
Ventricle 
Sample 
2 
1 1205 
1736.3 
2 1053 
3 751 
4 759 
5 1178 
6 985 
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Table 3: Endocardium Seeding Experiment 3 Nuclei Quantified by Image J 
Ventricle Sample 
Cell 
Count 
Sample Area 
(mm2) 
Cells per 
Area (Cell 
Count/mm2) 
Cells per 
Area 
Averaged 
for Ventricle 
Cells per Area 
Standard 
Deviation for 
Ventricle  
Seeding Efficiency: 
(100- ((Native Cells per 
Area-Seeded Scaffold 
Cells per Area)/Native 
Cells per Area))*100 
Left  
1 5 25.124 0.2 
2.0 1.9 0.1 
2 6 9.334 0.6 
3 76 26.760 2.8 
4 80 19.388 4.1 
Right 
1 68 31.173 2.2 
2.4 1.7 0.1 
2 126 25.8 4.9 
3 19 14.5 1.3 
4 30 21.3 1.4 
 
 
3.3.2 Coronary Seeding Experiments  
The novelty of the coronary seeding device is that it allows for a rabbit heart to be 
cannulated, held in place by the cannulation, and funnels a cell suspension into the aorta 
using gravity (Figure 21). We Utilized two techniques to ascertain the effectiveness of 
the coronary seeding device and stopcock for delivering cells into the coronary 
vasculature. First, in coronary seeding experiment 1, we tagged the endothelial cells 
with a cell tracer and imaged the scaffold using an IVIS machine. Second, we used 
histology to verify the results from the IVIS generated images. The IVIS generated 
images revealed endothelial cells successfully seeded into the left circumflex artery and 
right coronary artery (Figure 22). DAPI florescent nuclear stain and Masson’s Trichrome 
stain supported these finding. In coronary seeding experiment 2, nuclei quantification 
by Image J from DAPI fluorescent nuclear stain images revealed the region with highest 
cellular attachment was the coronary sinus (Table 5). The left coronary branch and right 
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coronary branch both yielded similar results for seeding efficiency with 0.134% and 
0.123% of cells reseeded into those regions respectively (Table 4, 5).  
 
Figure 21: Cell seeding device design (A) Solidworks designs showing cell seeding 
stand and funnel. (B) Representative image of cell seeding stand and funnel in use during 
coronary seeding experiments. Pink fluid is endothelial cell culture media, arrow points 
to cannulated scaffold. Several bottle caps and a p-cup filled with cell media was used to 
keep the cell-seeded scaffold suspended in media during cellular attachment to the 
coronary vasculature. (C) Aerial view of funnel. (D) Assembled cell seeding stand and 
A B 
C 
Coronary Seeding Device Design  
D 
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funnel adapted with tubing and y-connector for splitting fluid into both ventricles. This 
adaptation was used in hydrogel experiment 2 and all 3 endocardium reconstitution 
experiments. 
  
Figure 22: Coronary seeding experiments 1 and 2 histological and fluorescent 
analysis of cell-seeded coronary vasculature. (A) Left circumflex artery and (B) right 
coronary artery stained with DAPI fluorescent nuclear stain and Masson’s Trichrome 
stain. Bars are set to 100 µm. Red and black arrows depict cells seeded within the 
 95 
coronary vasculature. Cell tracer was used to fluorescently tag cells to identify their 
attachment locations along both branches of coronary arteries. Scaffold overlay images 
display the fluorescent regions overlaid onto the scaffold. Red and black arrows and 
circles depict regions of cellular attachment within both branches of coronary 
vasculature.  
Table 4: Native Heart Nuclei Quantified by Image J for Coronaries 
Sample Image 
Cell 
Count 
Area 
(mm2) 
Cells per Area Averaged for 
Coronary (Cell Count/mm^2) 
Cells per Area Standard Deviation for 
Coronary 
Coronary 
Sinus 
1 799 
0.569 
1599.9 245.8 
2 932 
3 904 
4 886 
5 1168 
6 776 
Circumflex 
Artery 
1 788 
1130.9 314.8 
2 553 
3 559 
4 927 
5 439 
6 597 
Right 
Coronary 
Artery 
1 826 
1665.8 740.2 
2 1563 
3 1604 
4 835 
5 1553 
6 1136 
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Table 5: Coronary Seeding Experiment 2 Nuclei Quantified by Image J 
Sample 
Origin  
Cell 
Count 
Sample 
Area 
(mm^2) 
Cells per 
Area (Cell 
Count/mm^2) 
Cells per 
Area 
Average 
for Vessel  
Cells per Area 
Standard 
Deviation for 
Vessel 
Seeding Efficiency: (100- 
((Native Cells per Area-Seeded 
Scaffold Cells per Area)/Native 
Cells per Area))*100 
Coronary 
Sinus 
(Sample 1) 
11 2.247 4.9 
3.3 2.2 0.2 
Coronary 
Sinus 
(Sample 2)  
4 2.284 1.8 
Left 
Coronary 
Artery  
14 5.8 2.4 
1.9 0.7 0.1 
Circumflex 
Artery  
5 3.6 1.4 
Right 
Coronary 
Artery 
(Sample 1) 
16 6.865 2.3 
2.3 0 0.1 
Right 
Coronary 
Artery 
(Sample 2) 
6 2.560 2.3 
 
 
3.3.3 Hydrogel Infusion Experiments 
Majority of the pores of the lyophilized samples in hydrogel experiment 1 did 
not have visual traces of solidified hydrogel depicted in Masson’s Trichrome stain 
(Figure 23). Instead the collagen-fibrin hydrogel is shown along the surface of the tissue. 
Wet tissue samples revealed regions of mixed collagen-fibrin hydrogel infused within the 
myocardium pores.  
The adaptor plug created for adapting the aortic root chamber could be used in 
combination with a metal ring to securely fit decellularized rabbit hearts (Figure 24). 
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Fluids used during experiments with the aortic root chamber and adaptor plug could still 
circulate throughout the chamber via the pores of the adaptor plug.  
In hydrogel experiment 2, Masson’s Trichrome stain revealed several patches of 
mixed collagen-fibrin hydrogel infused within the myocardium but not on the 
endocardium surface (Figure 25). Further analysis using Image J to quantify the amount 
of blue (collagen), red (fibrin), and pore area yielded large standard deviations for 
averages of decellularized samples (Table 6). Additionally, averages of hydrogel infused 
samples oriented along the circumferential axis yielded larger standard deviations than 
averages of hydrogel infused samples oriented along the perpendicular axis. A more in-
depth statistical analysis of the data generated by Image J using JMP revealed a 
significant difference between the orientation of the samples (Table 7). Linear contrast of 
perpendicular orientated hydrogel infused samples versus circumferential orientated 
hydrogel infused samples yielded a significant difference for collagen percent (Table 8) 
and pore percent (Table 10) and no significant difference for fibrin percent (Table 9). 
The same linear contrasts were performed for decellularized scaffold samples with no 
significant difference found for collagen percent, fibrin percent, or pore percent.  
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Figure 23: Hydrogel experiment 1 histological analysis of lyophilized and wet 
scaffold. (A) Wet scaffold tissue and (B) lyophilized scaffold tissue were left untouched 
for a control or treated with a mixed collagen-fibrin hydrogel. All hydrogel treated 
samples and controls samples were stained with Masson’s Trichrome stain. Bars are set 
to 100 µm. Black arrows depict hydrogel attached along the surface or infused within the 
pores of the samples.  
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Figure 24: Adaptor plug design. (A) Bioreactor components consisting of 1, metal ring, 
2, adaptor plug, 3, acrylic chamber, 4, chamber lid, 5, screws used to attach assembled 
device to an end-over-end rotator. (B) Solidworks designs showing bioreactor 
components in an expanded assembly. (C) Solidworks designs showing assembled 
bioreactor. (D) Solidworks design of the adaptor plug. (E) Solidworks designs showing 
adaptor plug’s bottom view with arrows depicting holes for allowing fluid flow. (F) 
Representative image of bioreactors and end-over-end rotator in use during endocardium 
Adaptor Plug Design 
A 
B D 
F 
E 
C 
1 
2 3 
4 5 
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reconstitution experiment 1. Red fluid is cell culture medium, black arrows point to heart 
scaffolds inside bioreactors.  
  
Figure 25: Hydrogel experiment 2 histological analysis of decellularized scaffold and 
hydrogel infused scaffold. (A) A Decellularized scaffold was used as a control to 
compare to (B) the hydrogel infused scaffold. All samples taken from the left ventricle, 
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right ventricle, and septum of both scaffolds were stained with Masson’s Trichrome stain. 
Samples from the left and right ventricles were oriented one of two ways, either along the 
ventricular circumferential axis or along the ventricular perpendicular axis. Bars are set to 
100 µm. Black arrows point to regions containing hydrogel infused into the ventricular 
wall.    
Table 6: Hydrogel Experiment 2 Masson's Trichrome Quantified by Image J 
Heart Orientation Ventricle 
Fibrin 
Percent 
Average 
Standard 
Deviation  
Collagen 
Percent 
Average 
Standard 
Deviation 
Pore 
Percent 
Average 
Standard 
Deviation 
Decellularized Perpendicular Left 17.8 16.6 27.2 22.6 41.6 10.5 
Decellularized Perpendicular Right 8.1 1.0 29.7 1.2 45.2 9.7 
Hydrogel 
Infused 
Perpendicular Left 7.1 6.3 36.7 6.1 27.4 4.7 
Hydrogel 
Infused 
Perpendicular Right 6.6 2.6 47.8 1.8 32.6 8.2 
Decellularized Circumferential Left 4.5 5.5 24.2 32.7 46.8 10.5 
Decellularized Circumferential Right 8.1 7.7 7.6 4.8 68.7 5.9 
Hydrogel 
Infused 
Circumferential Left 15.6 16.2 7.6 8.7 64.7 20.3 
Hydrogel 
Infused 
Circumferential Right 18.1 21.2 16.9 14.7 64.4 16.7 
 
 
Table 7: Hydrogel Experiment 2 Effect Summary from JMP 
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3.3.4 Endocardium Reconstitution Experiments  
The right ventricles of hearts A and B, left ventricle of heart B, and septum of 
heart A from endocardium reconstitution experiment 1 had cells adhered in thick 
layers on top of the ventricular surface in the DAPI fluorescent nuclear stain images 
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(Figure 26). The left ventricle of heart A revealed cells adhered to the surface of the 
ventricle but not to the magnitude of the other surfaces previously mentioned. In heart B, 
the septum had few regions of cells adhered to the surface but had cells integrate into the 
inside of the septum wall through a large pore. Masson’s Trichrome displayed several 
regions of mixed collagen-fibrin hydrogel adhered to the surfaces of the ventricular 
cavities. Many regions of adhered regions of hydrogel had cells embedded into its 
structure. Some pores within the myocardium were also infused with hydrogel. However, 
both DAPI fluorescent nuclear stain and Masson’s Trichrome stain revealed regions of no 
cellular or hydrogel attachment. DAPI fluorescent nuclear stain quantified by Image J 
yielded a 7.6% and 8.1% seeding efficiency for the right ventricles of hearts A and B 
respectively (Table 11). A seeding efficiency of 2.7% in the left ventricle of heart A and 
13.8% into the left ventricle of heart B was achieved. However, the standard deviation for 
the average cells per area of the left ventricles were very large compared to their 
respective averages. Compared to previous cell seeding experiments, the standard 
deviations for the average cells per area in the right ventricles where lower than before.  
The purpose-built bioreactor could store roughly 500 mL of media at once while 
housing the cell seeded scaffold at the center of the bioreactor (Figure 27). Three sterile 
filters allowed for gas exchange. Once fully assembled, the bioreactor could attach to the 
end-over-end rotator used in endocardium reconstitution experiment 1.     
 Endocardium reconstitution experiment 2 yielded patches of cellular and 
hydrogel attachment to the surfaces of the ventricular cavities depicted by DAPI 
fluorescent nuclear stain, Masson’s Trichrome stain (Figure 28), and SEM (Figures 29-
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31) of the left ventricle, right ventricle, and septum. IHC staining for laminin content 
revealed cells actively secreted laminin once seeded into the ventricles. SEM images 
depicted cells interacting with neighboring cells and integrated into the hydrogels. DAPI 
fluorescent nuclear stain quantified by Image J yielded a seeding efficiency of 2.9% and 
5.2% for the left and right ventricles respectively (Table 12). Standard deviations for the 
averages of cells per area in both ventricles were similar to the standard deviations found 
in endocardium reconstitution experiment 1. Masson’s Trichrome stain quantified by 
Image J for blue (collagen), red (fibrin), and pore area yielded overlapping standard 
deviations for fibrin area between like-ventricles of the cell seeded heart and 
decellularized heart (Table 13). Pore area and collagen area did not have overlapping 
standard deviations when comparing the right ventricles of the two hearts. However, pore 
area and collagen area did have overlapping standard deviation when comparing the left 
ventricles of the two hearts. Further analysis of the data generated by Image J using JMP 
revealed a significate difference between the two hearts but also a significant interaction 
between the two factors of heart and ventricle (Table 14). Using linear contrast of like-
ventricles between the two hearts, we only found a significant difference between the 
pore area of the right ventricles (Tables 15-17). Additionally, the standard deviations 
compared to their respective averages from the scaffold used in endocardium 
reconstitution experiment 2 were smaller than the standard deviations from the scaffold 
used in hydrogel experiment 2. 
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Figure 26: Endocardium reconstitution experiment 1 histological analysis of 
regenerated endocardium. (A) Left ventricle, (B) right ventricle, and (C) septum 
samples of seeded scaffolds A and B stained with DAPI fluorescent nuclear stain and 
Masson’s Trichrome stain. Bars are 100 µm. Red and black arrows depict seeded cells 
and infused hydrogel along ventricular surfaces. 
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Table 11: Endocardium Reconstitution Experiment 1 Nuclei Quantified by Image J 
Seeded 
Scaffol
d 
Ventricle Sample 
Cell 
Count 
Sample Area 
(mm^2) 
Cells per 
Area (Cell 
Count/mm^2
) 
Cells per 
Area 
Averaged 
for 
Ventricle 
Cells per 
Area 
Standard 
Deviation 
for 
Ventricle 
Seeding Efficiency: 
(100-((Native Cells 
per Area-Seeded 
Scaffold Cells per 
Area)/Native Cells 
per Area))*100 
A 
Left 
1 385 10.703 36.0 
52.2 35.0 2.7 
2 425 11.641 36.5 
3 711 6.794 104.7 
4 329 10.325 31.9 
Right 
1 1620 10.003 161.9 
147.9 36.0 7.6 
2 1740 9.566 181.9 
3 1086 7.233 150.2 
4 485 4.968 97.6 
B 
Left 
1 752 6.189 121.5 
265.9 176.5 13.8 
2 2425 6.854 353.8 
3 518 4.463 116.1 
4 3240 6.864 472.0 
Right 
1 1624 9.420 172.4 
157.9 15.5 8.1 
2 1707 11.985 142.4 
3 2094 12.323 169.9 
4 995 6.780 146.8 
 
 109 
 
Figure 27: Bioreactor design. (A) Bioreactor components consisting of 1, acrylic rings 
used as spacers for positioning cage inside of chamber, 2, chamber lid, 3, chamber, 4, 
cage, 5, cage lid, 6, screws and washers used to attach assembled device to the end-over-
end rotator. (B) Representative image of bioreactor and end-over-end rotator in use 
during cell seeding experiment. Red fluid is cell culture medium, black arrow points to 
caged-in heart scaffold. (C) Solidworks designs showing bioreactor components in an 
expanded assembly. (D) Assembled bioreactor. 
1 
2 
3 
4 
5 
6 
A B 
C D 
Bioreactor Design  
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Figure 28: Endocardium reconstitution experiment 2 histological analysis of native 
and regenerated endocardium. (A) DAPI fluorescent nuclear stain, (B) Masson’s 
Trichrome stain, and (C) IHC for laminin of samples taken from a native rabbit heart and 
the left ventricle, right ventricle, and septum of the cell-seeded scaffold. Bars are 100 µm. 
Red and black arrows (A, B) depict cells seeded on ventricular surfaces. Black arrows in 
(C) depict brown regions indicating a positive IHC reaction. Native DAPI fluorescent 
nuclear stain and Masson’s Trichrome stain images are previously shown in Figure 20 of 
this chapter. These images are shown again for comparison.  
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Figure 29: Endocardium reconstitution experiment 2 SEM analysis of the 
endocardium from left ventricle, right ventricle, and septum samples. (A) Native 
heart, (B) decellularized scaffold, and (C) cell-seeded scaffold images at 200x 
magnification and 1000x magnification. Native and decellularized scaffold images are 
previously shown in Figure 18 in chapter 2. These images are shown again for 
comparison.  
Table 12: Endocardium Reconstitution Experiment 2 Nuclei Quantified by Image J 
Ventricle Sample 
Cell 
Count 
Sample 
Area 
(mm^2) 
Cells per Area 
(Cell 
Count/mm^2) 
Cells per 
Area 
Averaged 
for 
Ventricle 
Cells per 
Area 
Standard 
Deviation for 
Ventricle 
Seeding Efficiency: (100-
((Native Cells per Area-
Reseed Cells per 
Area)/Native Cells per 
Area))*100 
Left 
1 1253 14.852 84.4 
55.5 25.2 2.9 
2 876 13.611 64.4 
3 383 13.370 28.6 
4 1074 27.664 38.8 
5 1365 22.268 61.3 
Right 
1 1008 13.042 77.3 
101.7 35.1 5.2 
2 979 7.534 129.9 
3 210 4.006 52.4 
4 1062 9.315 114.0 
5 484 3.590 134.8 
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Table 13: Endocardium Reconstitution Experiment 2 Trichrome Quantified by Image J 
Heart Ventricle 
Fibrin 
Percent 
Average 
Standard 
Deviation  
Collagen 
Percent 
Average 
Standard 
Deviation 
Pore 
Percent 
Standard 
Deviation 
Cell Seeded Left 5.5 3.1 15.6 4.6 46.1 8.8 
Cell Seeded Right 7.6 3.3 27.1 12.2 34.8 10.9 
Decellularized Left 4.5 5.5 24.2 32.7 46.8 10.5 
Decellularized Right 8.0 7.7 7.8 4.7 69.1 6.5 
 
 
Table 14: Endocardium Reconstitution Experiment 2 Effect Summary from JMP 
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 3.4 Discussion  
3.4.1 Endocardium Seeding Experiments  
We began researching endothelial cell seeing into the ventricular cavities of 
acellular scaffolds by attempting static seeding and centrifugal seeding to find an optimal 
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method for delivering cells to the endocardium. Endocardium seeding experiment 1 
focused on static seeding. Endothelial cells were delivered into the ventricular cavities of 
the decellularized scaffold via syringe injection through the aorta and pulmonary trunk. 
Following the conclusion of the experiment, we performed histological analysis on the 
cell-seeded scaffold. We cut circular samples from the left and right ventricles of a native 
rabbit heart and the cell-seeded scaffold to perform DAPI fluorescent nuclear stain, H&E 
stain, and Alcian Blue stain (Figure 19). We discovered cells attached to the ventricular 
surface of both ventricles of the cell-seeded scaffold using DAPI fluorescent nuclear 
stain, H&E stain, and Alcian Blue stain. Based off the DAPI fluorescent nuclear stain 
images, the attached cells remained viable after three days of static incubation. Cells also 
infiltrated through the surface pores of the ventricles and adhered to regions of the 
subendothelial layers of the endocardium and the myocardium. H&E stain, DAPI 
fluorescent nuclear stain, and Alcian Blue stain all supported these findings. 
The use of endothelial cells in cell seeding experiments on decellularized 
myocardial scaffolds have been referenced in literature.63,75,76 Weymann (2014) perfusion 
seeded human umbilical cord-derived endothelial cells into decellularized porcine hearts. 
They found variable effectiveness for recellularization with the best results near the site 
of injection.76 Using static seeding for delivering cells into cardiovascular tissue 
engineered constructs has been used in various research settings.52,79,95 However, static 
seeding has a great challenge to overcome. Because of the lack of media circulation, 
nutrient and oxygen exchange for seeded cells becomes poor overtime.52 In our 
experiment we only allowed the cell-seeded scaffold to remain static in media for 3 days 
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before fixing it for analysis. This allowed us to determine the effectiveness of our method 
for delivering cells prior to cell apoptosis due to a lack of nutrients and oxygen exchange. 
To analyze our results for endocardium seeding experiment 1, we used several 
histology stains that have been referenced in literature. H&E stain63,78,87,90,96, DAPI 
fluorescent nuclear stain63,75,78,79,87, and Alcian Blue stain78 have all been used by 
researchers to analyze acellular heart scaffolds seeded with various cell types. 
Following endocardium seeding experiment 1, several changes were made to 
our procedures for seeding cells into the ventricular cavities of decellularized scaffolds 
and producing results of our studies. After analyzing the results from H&E stains and 
Alcian Blue stains, we determined these two stains did not yield any additional 
information than DAPI fluorescent nuclear stain, aside from the Alcain Blue stain 
revealing glycosaminoglycan content. Glycosaminoglycan content can be used to help 
depict the structure of the scaffold. However, we concluded by using Masson’s 
Trichrome stain instead, we could analyze more components of the scaffold by staining 
for collagen content, muscle fiber content, and cellular content all at once. Moving 
forward, we no longer used H&E stain or Alcian Blue stain but continued using DAPI 
fluorescent nuclear stain and began using Masson’s Trichrome stain.  
Upon analyzing the histological stains for endocardium seeding experiment 1, 
we discovered circular samples were difficult for determining the orientation of the 
sample. The samples were embedded such that the endocardium, myocardium, and 
epicardium would be visible on each section of a histological slide. However, depending 
on where the sample was sectioned, each of the four sides of the section could be close to 
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equal lengths. Declaring one set of opposite sides the endocardium and epicardium was 
made difficult by the lack of tissue present on the histology slides. We decided for all 
following experiments where recognizing the orientation of the heart wall was important, 
we would cut rectangular samples from the ventricules. This allowed for each tissue 
section to have a much longer endocardium and epicardium, improving our ability to 
determine the orientation of the heart wall.  
After discovering the seeded cells were entering surface pores and attaching 
beneath the surface, we decided to pursue maximizing this occurrence as a means of 
inducing more cellular attachment. Endocardium seeding experiments 2 and 3 utilized 
a centrifugal seeding technique instead of a static seeding technique. A syringe was still 
used to inject the cell suspensions into each ventricle through the aorta and pulmonary 
trunk. However, instead of allowing the scaffold to set static following cell 
administration, we placed the scaffold into a 50mL Bio-Reaction tube and centrifuged it 
for 10 minutes at 500G. Our goal was to force the seeded cells into the surface pores of 
the ventricles to surround the cells with available attachment sites within the scaffold.  
We accomplished this goal with limited success. More cells could be found inside 
the myocardium and subendothelial layers of the endocardium for endocardium seeding 
experiments 2 and 3 than in endocardium seeding experiment 1. DAPI fluorescent 
nuclear stain and Masson’s Trichrome stain of the two ventricles depict these findings 
(Figure 20). However, after we quantified the DAPI fluorescent nuclear stain images 
using Image J, we discovered samples from the same ventricle had high standard 
deviations for cells per area (Table 3). This suggest cells were unable to uniformly 
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infiltrate the ventricular surfaces of the acellular scaffold following injection. Instead, the 
locations of cell administration inside the ventricles yielded the highest cell densities. 
Using centrifugation could have prevented the suspended cells from distributing along 
the ventricular surfaces by forcing the cells proximal to the injection site downward, 
embedding them into the local surface pores. After performing DAPI fluorescent nuclear 
stain quantification by Image J for native rabbit heart samples (Table 2), we calculated 
the seeding efficiency of endocardium seeding experiment 3 as a representation of the 
number of cells re-introduced into the decellularized heart wall. Our seeding efficiencies 
for both ventricles were below 1%. While this would be a poor percentage for tissue 
engineering the whole heart, our goal was to recellularize the endothelium lining of the 
ventricular cavities.   
Similar to the histology stains performed in endocardium seeding experiment 1, 
Masson’s Trichrome stain has been used by several researchers for cell-seeding 
experiments on decellularized myocardial scaffolds.63,78,96 Additionally, centrifugation as 
a cell seeding technique has been previously referenced in literature with limited 
success.52,95 Dar (2002) created porous alginate scaffolds 5mm in diameter and 1 mm in 
thickness. They seeded the scaffolds with varying cell densities of cardiac cells using a 
centrifugation speed of 1000g for 6 mins. Afterwards, they discovered centrifugation 
influenced a uniform cell distribution to occur on top of the surfaces and beneath the 
surfaces of the porous alginate scaffolds.97 However, one big limitation of their study was 
the small size of the alginate scaffolds. Some literature reports suggest centrifugation 
may negatively impact the morphology of cells when used to seed them onto constructs.95 
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However, our DAPI fluorescent nuclear stain revealed cells with intact circular nuclei, 
indicating cell viability after centrifugation.  
 
3.4.2 Coronary Seeding Experiments 
We designed a seeding device composed of a stand and funnel to assist with 
gravitational cell seeding. (Figure 21). Our seeding device attached and supported our 
scaffold at the cannulation while not contacting the scaffold’s surface. We designed our 
seeding device to inhibit contact with the scaffold’s surface to ensure regions of the 
coronary vasculature were not impeded by contact with a foreign object during cell 
seeding. This was important to us because we did not want to reduce potential flow 
through any of the coronary vessels. Additionally, the funnel allowed us to administer 
cells through a stopcock. The stopcock was used to slow down the speed of the cell 
suspension. To successfully seed cells into the coronary vasculature, we needed to apply 
gentle pressure to the aortic valve to influence the aortic valve to close. By closing the 
aortic valve, the only remaining pathways for the cell suspension to flow was into the left 
and right coronary branches.   
After designing and 3-D printing the seeding device, we began coronary seeding 
experiment 1 by administering endothelial cells tagged with immunofluorescence into a 
decellularized scaffold. After imaging the scaffold with an IVIS machine (Figure 22), we 
confirmed cells adhered to the coronary vasculature along the large vessels of the left and 
right branches. However, we did not see evidence of cells seeded into the small vessels of 
the coronary vasculature. This suggest the cell suspension followed the path of least 
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resentence through the coronary vasculature by primarily flowing through large vessels 
until reaching the coronary sinus. We also discovered the scaffold itself may provide 
background fluorescence due to the fluorescing superior and inferior vena cava and 
pulmonary veins and arteries. To verify cellular attachment to the large vessels of the 
coronary vasculature, we cut rectangular sections of regions containing the right coronary 
artery and left coronary/circumflex artery from our cell-seeded scaffold to perform 
histology. DAPI fluorescent nuclear stain and Masson’s Trichrome stain revealed cells 
adhered to vessel walls.  
Gravitational seeding has been referenced in literature many times for seeding 
cells into vasculature protheses.95,98 However, in these studies the term gravitation 
seeding was often interchangeable with static seeding.95 To distinguish the difference 
between endocardium seeding experiment 1 using static seeding and our coronary 
seeding experiments 1 and 2 using gravitational seeding, it is important to note that in 
our static seeding experiment the cell suspension remained stationary after administration 
while in our gravitational seeding experiment, the cell suspension continued to flow 
following administration due to the force of gravity. In literature, these terms for seeding 
are interchangeable because once a cell suspension is static, the only force acting on cells 
is gravity pulling them towards the scaffold.98  
In cell seeding experiments, other researchers have also reported the use of cell 
tracer kits to verify the location of their adhered cells on scaffolds.99 Additionally, 
endothelial cell seeding through the aorta has been previously performed according to 
literature.63,75,76 Robertson (2014) attempted three cell seeding techniques to re-
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endothelialize the surfaces of the ventricular cavities of decellularized rat hearts. Out of 
these three cell administration techniques, all involved endothelial cells entering the aorta 
either through the brachiocephalic artery or directly into the aorta itself.75 Ott (2008) 
performed antegrade perfusion of endothelial cells through the aorta of decellularized rat 
hearts. In his study, he not only found endothelial cells adhered to the surfaces of the 
ventricular cavities but also adhered to the lumen of large and small coronary vessels in 
the myocardium.63 Weymann (2014) attempted a scale up study by perfusion 
administration of cardiac cells through the aorta of a decellularized porcine scaffold. 
Following administration of several cardiac lineage cells, they discovered monolayer 
patches of endothelial cells were adhered inside the coronary vasculature partially 
covering the endothelium.76 However, in these studies, endothelial cells were 
administered using perfusion with the intent of bypassing the aortic valve. In our study 
we aimed at closing the aortic valve to allow greater entry into the coronary vasculature. 
Regardless, these literature findings help confirm the applicability of seeding endothelial 
cells into the coronary vasculature by administering cells through the aorta.  
To verify the reproducibility of the histology results from coronary seeding 
experiment 1 and to determine the distribution of the seeded endothelial cells in the 
coronary vasculature, we attempted coronary seeding experiment 2. The second 
coronary experiment was performed with the same protocol as the first coronary seeding 
experiment except the endothelial cells were not tagged with a cell tracer. The histology 
conducted afterwards verified the reproducibility of the histology results from coronary 
seeding experiment 1. Nuclei quantified from DAPI fluorescent nuclear stain images by 
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Image J from coronary seeding experiment 2 revealed the highest cell density was at 
the coronary sinus (Table 5). The large vessels of the left branch and right branch of 
coronary vasculature yielded similar results for cell densities. These findings support our 
theory of the cell suspension following the path of least resistance through the coronary 
vasculature. If the cell suspension were to flow mainly through the large vessels and stop 
at the coronary sinus, we would expect the coronary sinus to have the largest cell density 
after the experiment concluded. To quantify the seeding efficiency’s in the regions 
containing large coronary vessels, we first used Image J to quantify the nuclei of native 
heart samples from the same regions stained with DAPI florescent nuclear stain (Table 
4). Afterwards, we found the seeding efficiency’s to be 0.203%, 0.134%, and 0.123% for 
the coronary sinus, left coronary artery, and right coronary artery respectively. Similar to 
endocardium seeding experiment 3, our seeding efficiencies for coronary seeding 
experiment 2 was below 1%. While this is a poor percentage for recellularizing the 
entire regions quantified, our goal was to seed endothelial cells onto the endothelium of 
the coronary vasculature. 
 
3.4.3 Hydrogel Infusion Experiments 
After performing experiments for recellularizing the coronary vasculature and 
ventricular endocardium, we decided to move forward with recellularizing the 
endocardium as the primary focus of this project. To improve cellular adhesion to the 
ventricular endocardium, we decided to incorporate hydrogels into our experiments. 
Instead of seeding cells on the surface and inside the pores of the subendothelial 
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endocardium layers, we transitioned to applying hydrogels prior to cell seeding to yield a 
more favorable environment for cellular adhesion and activity. Additionally, applying 
hydrogels could compensate for the partial distribution of the basal lamina following 
decellularization. However, by infusing hydrogels into the ventricles of our scaffolds, the 
surface pores originally utilized by cells in endocardium seeding experiments 2 and 3 
may become filled with hydrogel instead. This changes our strategy of recellularizing the 
endocardium from embedding cells into the scaffold to recreating the whole endocardium 
on top of the ventricular surface.  
Collagen and fibrin hydrogels have been used with various cell lines in literature. 
Collagen hydrogels have been shown to have better mechanical properties than fibrin 
hydrogels, while fibrin hydrogels have been shown to induce more endothelial cell 
activity and communication than collagen hydrogels.100,101 By including a collagen 
hydrogel in the ventricles of our scaffold, we could supply the scaffold’s extracellular 
matrix with collagen proteins for structural support. Also, using a fibrin hydrogel with 
endothelial cells could induce more cellular activity, influencing the cells to secrete some 
of the proteins of the basal lamina negatively impacted by decellularization. 
Rao (2012) tested varying ratios of mixed collagen-fibrin hydrogel concentrations 
with mesenchymal stem cells and endothelial cells. They discovered, by increasing the 
amount of fibrin included in the collagen-fibrin hydrogels, the amount of vessel like 
formations secreted by the cells also increased.100 This is evident of fibrin hydrogels 
inducing cellular communication and activity through influencing cells to form vessel 
like channels with one another. Cummings (2004) researched gel compaction with 
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smooth muscle cells suspended in either collagen, fibrin, or a 50/50 mixture of collagen-
fibrin hydrogels. The 50/50 mixture of collagen-fibrin hydrogels yielded the same gel 
compaction as fibrin hydrogels but more gel compaction than collagen hydrogels.101 
When seeded cells induces a hydrogel to compact, the result is an increase in cell density 
due to a smaller volume of hydrogel. This is useful to our research because we can create 
a more cell dense reconstituted endocardium if the cells are suspended in a hydrogel that 
condenses on the ventricular surface of our scaffold. 
To begin incorporating collagen-fibrin hydrogels to our experiments, we first 
researched if lyophilizing our scaffold would create a more favorable environment for 
integrating the hydrogels. Circular scaffold samples were either left untouched (wet 
tissue) or lyophilized before administering a mixed collagen-fibrin hydrogel on top of the 
scaffold. Masson’s Trichrome stain revealed wet tissue yielded more hydrogel integration 
into the scaffold’s pores while lyophilized tissue resulted in the hydrogel primarily 
adhered to the scaffold’s surface (Figure 23).  However, these results are not consistent 
with the effect of lyophilizing tissue on improving cellular infiltration in literature.  
Lyophilization has been used in other tissue engineering applications such as 
developing tissue engineered cartilage. Nettles (2002) lyophilized chitosan scaffolds and 
seeded them with chondrocytes. The lyophilization was performed to increase porosity 
with the rationale of a more porous scaffold would induce more cellular infiltration, 
resulting in a uniform cell density.102 Freytes (2008) seeded equal concentrations of 
fibroblast onto either lyophilized or wet decellularized porcine urinary bladder samples. 
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After 7 days of cell culture on the scaffolds, more cells were found in the lyophilized 
samples than the wet samples.103 
We believe our results from hydrogel experiment 1 are inconsistent with the 
findings in literature for two reasons. One, our scaffold does not have many surface 
pores. In our decellularized scaffold SEM images (Figure 18), the surface of our scaffold 
appeared to be confluent. However, in endocardium seeding experiments 1-3 we could 
seed cells beneath the surface of our scaffold, suggesting the existence of some surface 
pores. Second, the lyophilized scaffold samples did not have fluid surrounding them for 
the duration of the experiment. This allowed the hydrogel to remain on top of the samples 
while solidifying. Because the well plates containing the wet samples did have media 
filled to the surface of the samples, the hydrogel administered to these samples could 
have flowed into the media. This would allow the hydrogel to diffuse into the large 
circumferential pores from the sides of the sample and solidify. After analyzing the 
results from hydrogel experiment 1, we decided to move forward without using 
lyophilization. Since the hydrogel could not infiltrate beneath the surface of the 
lyophilized scaffold, lyophilizing the scaffold would only create larger pores beneath the 
surface rather than provide entryways for hydrogels to intimately fuse within the scaffold.  
To maximize hydrogel attachment to the ventricular surface, we decided to 
include rotation and centrifugation into our methods for administering the mixed 
collagen-fibrin hydrogel. Rotation was incorporated to influence the hydrogel entrapped 
in the ventricles to coat the entire ventricular surface. Centrifugation was included to 
force the hydrogel into any potential surface pores. To accomplish rotation, we designed 
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an adaptor plug to be used with an acrylic chamber and metal ring originally designed for 
housing an aortic root. The chamber mounted onto an end-over-end rotator that used 
LabVIEW to control speed, duration, and number of rotation cycles. The adaptor plug 
was designed to secure our scaffold at the bottom of the chamber, limiting the available 
room for the scaffold to move while rotating. This was important to us because we did 
not want the seeded cells to experience impact forces that may affect viability. However, 
we also took into consideration of limiting too much space by applying pressure on the 
scaffold and causing the filled ventricles to leak. To incorporate this rotation technique 
with cell seeding experiments, we also designed multiple holes in the adaptor plug. The 
holes were strategically placed to allow circulation for cell media to supply nutrients and 
oxygen to a cell-seeded scaffold.  
For hydrogel experiment 2, gravity was used to administer a mixed collagen-
fibrinogen hydrogel into both ventricles of the decellularized scaffold through the aorta 
and pulmonary trunk. After rotation and centrifugation, excess hydrogel solution was 
removed from the ventricles and replaced with a thrombin solution. We administered the 
thrombin solution separately to prevent the fibrin portion of the hydrogel from solidifying 
before removing the excess hydrogels from the ventricles. 
Samples taken from hydrogel experiment 2 were embedded one of two ways. 
Either oriented along the ventricular circumferential axis to produce histological slides 
with a visible endocardium, myocardium and epicardium or oriented along the ventricular 
perpendicular axis to produce histological slides with a visible myocardium. This allowed 
use to view pores from two different direction and assess if the hydrogel was infusing in 
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one direction better than the other. Masson’s Trichrome stain revealed hydrogel solidified 
inside the pores of the scaffold in both orientations (Figure 25). Image J was used to 
quantify the collagen (blue) area, fibrin (red) area, and pore area of the Masson’s 
Trichrome images. We performed a student’s t-test on decellularized samples and 
hydrogel infused samples taken from the same ventricle and orientated in the same 
position. We found a significant difference (p-value=0.01) in the collagen percent of the 
right ventricle samples embedded on the ventricular perpendicular axis. All other 
comparisons did not reveal a significant difference. However, the standard deviations 
were large compared to their respective averages for many of the decellularized scaffold 
samples. This may reflect poorly on the consistency of some of the chemicals from 
Masson’s Trichrome stain on decellularized tissue.  
Further statistical analysis was performed using JMP. We discovered sample 
orientation cumulatively yielded a significant difference (Table 7). To determine if this 
discovery holds true for all the data sets (collagen percent, fibrin percent, and pore 
percent) we performed a three-way factorial ANOVA for each data set (Tables 8-10). We 
discovered a significant difference in orientation for collagen percent and pore percent 
but not for fibrin percent. Next, we used linear contrasts to determine if the orientation 
effect was significantly different for both the hydrogel heart and the decellularized heart 
in each data set. In the linear contrasts for collagen percent and pore percent, we found a 
significant difference for the orientation effect occurred for hydrogel samples but not for 
decellularized samples. Similar to the three-way factorial ANOVA, fibrin percent did not 
have a significant difference for either heart in the linear contrasts.  
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If the orientation effect were to be true for both hearts in the collagen percent and 
pore percent data sets, then there would not be a significant difference created by infusing 
the hydrogel. However, since this orientation effect holds true for only the hydrogel 
infused heart, then it is an indication of the hydrogel infiltrating in one direction better 
than the other. This is important to us because we want the hydrogel to fill more into 
perpendicular pores than circumferential pores. By the hydrogel filling into perpendicular 
pores, we can increase surface area for cellular attachment when cell-seeding. 
Additionally, the standard deviations were larger for circumferential oriented hydrogel 
infused samples than perpendicular oriented hydrogel infused samples. This suggests 
there was poor distribution of the hydrogel into circumferential oriented pores. We 
believe the orientation effect occurred from centrifugation. The centrifugal force pushed 
the fibrinogen and collagen proteins downward against the ventricular surface. This could 
have caused the proteins to infiltrate into the perpendicular oriented pores in a greater 
magnitude and more consistently than the circumferential oriented pores.  
One inconsistency for this data is the lack of significant difference in fibrin 
percent for the two orientations. We can confirm the fibrin portion of the hydrogel did 
solidify in the images from Masson’s Trichrome stain. However, following this 
experiment we realized the calcium concertation needed for the solidification of the fibrin 
hydrogel and the phosphate concentration used to buffer the collagen hydrogel may have 
interacted when mixed together. An aqueous solution containing phosphate and calcium 
may form calcium-phosphate precipitants. If this occurred during the hydrogel 
experiment, then the solidification of either collagen or fibrin may have been affected. 
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Moving forward we decided to apply the collagen and fibrin hydrogels separately in a 
layer-by-layer method to prevent the interaction of calcium and phosphate and to provide 
a method for reconstituting the endocardium analogous to native endocardium structure. 
It is important to note that hydrogel experiment 2 was performed after endocardium 
reconstitution experiment 1. This explains why the layer-by-layer method was not 
applied until endocardium reconstitution experiments 2 and 3.  
A third hydrogel experiment was not performed to test the hydrogel integration 
using the layer-by-layer method. We did not believe a third hydrogel experiment would 
add any additional information that cannot be found from quantifying the Masson’s 
Trichrome stain images of endocardium reconstitution experiment 2. The only 
difference between the Masson’s Trichrome stain of a hydrogel experiment and an 
endocardium reconstitution experiment would be the addition of cells and their effect on 
fibrin. The effect of cells on fibrin would be a decrease in the amount of fibrin present on 
the scaffold. This will not impact the quantification of collagen content. Also, since fibrin 
content will be degraded by cells over time, the fibrin content will not impact the long-
term change in pore area. 
 
3.4.4 Endocardium Reconstitution Experiments  
Before hydrogel experiment 2, we performed endocardium reconstitution 
experiment 1 using a mixed collagen-fibrin hydrogel with the addition of cells. We 
seeded more cells into the ventricles of both hearts than before to increase cellular 
attachment to the ventricular surface.  The adaptor plug, acrylic chamber, metal ring, and 
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end-over-end rotator was used to provide rotational cell seeding and hydrogel infusion 
(Figure 24).  
Following the conclusion of endocardium reconstitution experiment 1 we 
found multiple patches of cells and hydrogel adhered to the ventricular surfaces of both 
hearts. DAPI fluorescent nuclear stain revealed surface regions with cells adhered as 
monolayers and multiple layers (Figure 26). Masson’s Trichrome stain confirmed these 
findings and additionally depicted regions of hydrogel with mixed blue and red color, 
confirming the solidification of both components of our mixed hydrogel. We also found 
regions of hydrogel and cells embedded into some of the pores beneath the ventricular 
surface. This is evident of cells and hydrogel infiltrating into some of the surface pores. 
However, despite our progress with reconstituting the endocardium, were not able to coat 
the entire surface of the ventricular cavities with cells and hydrogel. Interestingly, we did 
not find hydrogel attached to the surfaces of the ventricles after hydrogel experiment 2. 
The addition of cells to the hydrogel may have created a mixture more favorable to 
attachment along the ventricular surface.   
DAPI fluorescent nuclear stain quantified by Image J revealed much higher 
seeding efficiencies than previous endocardium and coronary seeding experiments. The 
seeding efficiencies were 2.71, 7.61, 13.78, and 8.13 in the left ventricle of heart A, right 
ventricle of heart A, left ventricle of heart B, and right ventricle of heart B respectively 
(Table 11). However, the left ventricle of heart B and heart A had a high standard 
deviations compared to their respective cells per area averages. This is suggestive of poor 
cellular distribution in the left ventricle. In the right ventricle, the standard deviations 
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compared to their respective averages were lower than previous cell seeding experiments, 
evident of improved cellular distribution.  
While performing endocardium reconstitution experiment 1, we discovered the 
amount of media that can be stored in the chambers was not large enough to support the 
number of seeded cells for more than 12 hours at a time. Additionally, as the end-over-
end rotator rotated the chambers, the cell seeded scaffold would spend several seconds 
every minute engulfed in an air bubble. When filling the chambers with media, we left 
room for an air bubble at the top of the chamber for gas exchange with the sterile filters. 
As the chamber rotated, the air bubble would travel to the most elevated region of the 
chamber. This caused the air bubble to travel to the bottom of the chamber while the 
chamber was upside down. During this window of every rotation, the scaffold would rest 
on top of the adaptor plug and be suspended in air instead of media. We decided to design 
a new bioreactor to resolve these issues.  
The bioreactor was designed with multiple desired inputs. We developed a 
pyramidal cage for confining the position of the scaffold to the center of the bioreactor 
while leaving ample space for media circulation to the scaffold. The acrylic chamber was 
designed to be transparent, capable of attaching to the end-over-end rotator, and house 
500 mL of cell media. We made a new acrylic chamber lid to permit the attachment of 
three sterile filters for improving gas exchange. O-ring seals were used to secure the 
pyramidal cage lid and chamber lid in place. However, due to the weight of the 
bioreactor, we decided to incorporate screws through the lid of the chamber for attaching 
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to the end-over-end rotator. The screws acted to attach the bioreactor to the end-over-end 
rotator and add support for securing the chamber lid.  
We performed endocardium reconstitution experiment 2 using the new 
bioreactor and a modified protocol with a layer-by-layer method for delivering cells and 
hydrogels.  The first layer was aimed at rebuilding the subendothelial endocardium. In 
the tunica propria the primary components are fibroblast cells and a loose connective 
tissue composed of collagen.8 We added a collagen hydrogel to the scaffold’s ventricles, 
followed by fibroblast cells differentiated from ADSCs, and then an additional coating of 
collagen hydrogel. These components would ideally create a layer of loose collagen 
fibers with fibroblast embedded into the structure. The second layer was aimed at 
developing the endothelial layer of the endocardium. Fibrin hydrogel was applied over 
top of the first layer to stimulate endothelial cell attachment and activity. Afterwards we 
seeded the ventricles with endothelial cells. The endothelial cells in presence of the fibrin 
hydrogel would ideally secrete their own basal lamina components and communicate 
with one another to form a dense tightly sealed endothelium.  
The results from endocardium reconstitution experiment 2 indicate we had 
partial success for rebuilding the endocardium. DAPI fluorescent nuclear stain revealed 
multiple regions of cells adhered to the surface of the ventricles (Figure 28). Masson’s 
Trichrome stain confirmed these findings and displayed surface areas with collagen and 
fibrin hydrogels attached as well. However, these findings were not consistent throughout 
the ventricles. Multiple regions did not depict hydrogels or cells adhered to the surface. 
Instead of rebuilding the entire endocardium, the endocardium was reconstituted in 
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segmented patches along the ventricular surfaces. Also, in the Masson’s Trichrome stain 
images, there are some regions of adhered cells and hydrogels lacking components. Some 
of the regions did not stain for cells or one or both hydrogels. In multiple patches of 
reconstituted endocardium, it is difficult to discern the effectiveness of both layers. The 
scaffold naturally stains blue in Masson’s Trichrome stain because of its’ collagenous 
structure and cells stain dark red or black. With the scaffold naturally staining blue, some 
regions are difficult to determine if or how much collagen hydrogel adhered to the 
surface of the ventricles. Additionally, with dark red or black stained cells suspended in 
the collagen and fibrin hydrogels, some regions do not have distinct layers of color. This 
makes it challenging to assess the presence of all the added components in those patches 
of reconstituted endocardium.  
Our seeding technique yielded hydrogel and cell infiltration into the coronary 
vasculature and some of the pores underneath the surface of the ventricles. DAPI 
fluorescent nuclear stain and Masson’s Trichrome stain both yielded evidence of this 
occurrence. The same cell seeding stand and funnel used in coronary seeding 
experiments 1 and 2 was used in endocardium reconstitution experiments 1-3. A y-
connector and two additional pieces of tubing replaced the stopcock to allow flow into 
both ventricles of the scaffold. Because hydrogels and cells suspensions filled the left 
ventricle through the aorta, the coronary vasculature was also seeded.  
IHC staining for laminin and SEM was performed to further confirm the finding 
from histological stains and to assess cellular activity. Laminin IHC was counter stained 
with hematoxylin to yield a light purple background with dark purple cells. Cells can be 
 136 
visualized on the surfaces of ventricles along with regions of positive stained laminin 
proteins. Brown regions depicting a positive reaction with laminin were also found in the 
coronary vasculature and in some of the pores beneath the ventricle surface. These results 
indicate cellular activity through secretion of basal lamina components. SEM images 
reveal patches of adhered cells and hydrogels on the ventricle walls (Figure 29). Cells 
were intimately integrated with the hydrogels and actively interacting with neighboring 
cells. 
DAPI fluorescent nuclear stain quantified by Image J revealed a large standard 
deviation compared to the cells per area average for the left ventricle (Table 12). This is 
indicative of poor cellular distribution in the left ventricle similar to endocardium 
reconstitution experiment 1. The odd phenonium of having poor cellular distribution in 
one ventricle but not the other may be linked to the coronary vasculature infiltration. The 
left ventricle was seeded with hydrogels and cells from the aorta, giving passage way to 
both the left ventricle and the coronary vasculature. It is possible that enough of the cell 
suspension and hydrogel solutions entered the coronary vasculature to negatively impact 
the seeding outcomes in the left ventricle. The seeding efficiencies of endocardium 
reconstitution experiment 2 were also similar to endocardium reconstitution 
experiment 1 with 2.877 percent of cells re-seeded into the left ventricle and 5.235 
percent of cells re-seeded into the right ventricle.  
Masson’s Trichrome stain quantified by Image J yielded higher averages for 
collagen percent and lower averages for pore percent compared to the same ventricles 
and orientation from hydrogel experiment 2 (Table 6, 13). However, majority of the 
 137 
standard deviations for the averages between the two experiments are too large to declare 
a significant difference by a students t-test. Only pore percent between the right ventricles 
yielded a significant difference (p-value=0.02), while all other comparisons for collagen 
percent, pore percent, and fibrin percent were not significantly different.  
The averages for fibrin percent from endocardium reconstitution experiment 2 
are lower than the averages from hydrogel experiment 2. A lower fibrin percent was 
expected because cells degraded the fibrin hydrogel over several days of culture in the 
scaffold. Also, in endocardium reconstitution experiment 2, the standard deviations 
compared to their respective averages were much lower than the standard deviations 
compared to their respective averages in hydrogel experiment 2. This suggests the layer-
by-layer method improved hydrogel distribution. Overall, the data gathered from 
hydrogel experiment 2 and endocardium reconstitution experiment 2 were not 
conclusive but indicative of the layer-by-layer method yielding a more optimal hydrogel 
infusion than applying the hydrogels mixed together. 
We used the same data gathered from the decellularized scaffold in hydrogel 
experiment 2 to compare with the scaffold from endocardium reconstitution 
experiment 2. A student’s t-test was performed on decellularized samples orientated 
along the circumferential axis and the reconstituted endocardium scaffold samples taken 
from the same ventricle. We discovered a significant difference between the right 
ventricle collagen percent (p=.02) and the right ventricle pore percent (p=.0008). 
However, we did not find a significant difference between left ventricle collagen percent 
and pore percent. This may be explained by the thickness difference between the left 
 138 
ventricle and right ventricle. Because the left ventricle is thicker than the right ventricle, 
more hydrogel infusion would be needed in the left ventricle of the reconstituted 
endocardium scaffold to determine a significant difference from the left ventricle of the 
decellularized scaffold. Even though we cannot show a significant difference between the 
two left ventricles, there was still enough hydrogel infusion into the left ventricle to make 
an impact on the seeded cells.  
Using the data from Masson’s Trichrome stain quantified by Image J of 
decellularized scaffold samples and reconstituted endocardium samples, we performed a 
more in-depth statistical analysis using JMP (Table 14).  A significant difference 
between the two hearts and an interaction between hearts and ventricles was discovered. 
To diagnose the cause of the interaction between hearts and ventricles we performed two 
linear contrast for each data set (collagen percent, fibrin percent, and pore percent) to 
compare the samples from the left ventricles and compare the samples from the right 
ventricles (Table 15-17). The only significant difference discovered was between right 
ventricles using the data from pore percent. However, the data between right ventricles 
using collagen percent was close to a significant difference with a p-value of 0.11. Based 
off these results, we can conclude there was not a significant difference between the left 
ventricles of the two scaffolds but there was a difference between the right ventricles of 
the two scaffolds. This is in agreeance with the student’s t-test we performed on this data. 
We are the first researchers to attempt reconstitution of the endocardium inside 
acellular myocardial scaffolds. Our final technique used a layer-by-layer method for 
applying each component of the endocardium to our scaffold. Layer-by-layer techniques 
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have been used in tissue engineering for other applications. There are several ways to 
produce biomaterials using a layer-by-layer method. Each layer can be created with the 
ability to attract the next layer. This technique develops multilayered biomaterials with 
intimately joined layers. Processes such as charge transfer, biological recognition, 
covalent bonding, hydrogen bonding, electrostatic interactions, and hydrophobic 
interactions have been referenced in literature for creating layered biomaterials used in 
tissue engineering.104 Others have explored rapid prototyping methods for creating each 
layer individually and using various techniques to join the independent layers.105 One 
particular rapid prototyping method used in tissue engineering for developing organs is 3-
D printing layers of matrix or cells.106 While these methods relay on computer aided 
techniques or interactions between layers for building complex biomaterials, we explored 
a different technique for building our reconstituted endocardium. Rotational forces were 
applied to our hydrogels and cells to develop a more uniform coating of each layer in the 
acellular scaffold’s ventricles and centrifugation forces were applied to force the proteins 
and cells to the surface of the previous layer. 
Layer-by-layer techniques have also been used with endothelial cells. Boura 
(2005) used a layer-by-layer method to develop a biomaterial capped with poly(d-lysine) 
(PDL) or poly(allylamine hydrochloride) (PAH). Endothelial cells were seeded on top of 
the multilayered biomaterials and seeded on top of PAH monolayers, PDL monolayers, 
glasses, and fibronectin-coated glasses for comparison. They discovered the multilayered 
biomaterials yielded higher cell viability over several days of culture compared to the 
monolayers of PAH and PDL.107,108 Similarly, we discovered using hydrogel layers with 
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our cells resulted in greater seeding efficiencies into the ventricles of our acellular 
scaffolds.   
 
 3.5 Conclusion  
Following endocardium seeding experiments 1-3, we determined our 
decellularized scaffold can support cellular attachment and viability. Static seeding used 
in endocardium seeding experiment 1 resulted in cells attached to the ventricular 
surfaces of the scaffold. Cells were also able to infiltrate through the surface pores of the 
ventricular cavities and adhere to attachment sites within the subendothelial layers of the 
endocardium and adhere to the myocardium. Endocardium seeding experiments 2 and 
3 yielded more cellular attachment beneath the surface of the ventricular cavities by using 
centrifugation. However, DAPI fluorescent nuclear stain images quantified for cell nuclei 
by Image J revealed poor cellular distribution in both ventricles of the scaffold.    
Based off the results from coronary seeding experiments 1 and 2, we 
determined our seeding device and technique can effectively induce endothelial cells to 
infiltrate the large vessels of the coronary vasculature. However, we were unable to 
effectively seed endothelial cells into the smaller vessels. By using Image J to quantify 
the nuclei from the DAPI fluorescent nuclear stain images, we discovered the coronary 
sinus yielded the highest cell density and seeding efficiency. The right and left coronary 
arteries yielded similar results for cell densities and seeding efficiencies compared to one 
another.    
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After hydrogel experiment 1, we decided against lyophilization of scaffold prior 
to hydrogel infusion and cell seeding. Lyophilization increased the size of the pores 
beneath the ventricular surface but did not impact hydrogel infiltration into those pores. 
In hydrogel experiment 2 we discovered our procedure induced hydrogel infiltration 
beneath the surface of the ventricles but did not induce hydrogel adhesion to the surface. 
Using JMP to perform statistical analysis on the data generated by Image J from 
Masson’s Trichrome stain images, we concluded the hydrogel infiltrated pores oriented 
along the ventricular perpendicular axis better than pores oriented along the ventricular 
circumferential axis.  
Our endocardium reconstitution experiments 1 and 2 yielded patches of 
reconstituted endocardium along the ventricular surfaces of our scaffolds. DAPI 
fluorescent nuclear stain and Masson’s Trichrome stain depict this occurrence in 
endocardium reconstitution experiments 1 and 2. Based off the data generated by 
Image J quantification of DAPI fluorescent nuclear stain images, our cell seeding and 
hydrogel infusing techniques yielded improved cellular adhesion in both ventricles and 
cellular distribution in the right ventricle compared to previous cell seeding experiments. 
After adapting a layer-by-layer method for reconstituting the endocardium, Masson’s 
Trichrome stain images quantified by Image J showed an improvement for hydrogel 
distribution in both ventricles. Additionally, histological analysis and SEM images 
revealed hydrogel adhered on the surface of both ventricles. Laminin IHC and SEM 
images depicted cells interacting with one another, secreting basal lamina proteins, and 
intimately integrated with the hydrogels. However, our major limitation in these studies 
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was the inability to cover the whole ventricular surface with our reconstituted 
endocardium. Instead, we were only able to apply patches of reconstituted endocardium 
dispersed throughout the ventricles.  
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CHAPTER FOUR 
CONCLUSIONS AND RECOMMENDATIONS FOR THE FUTURE 
 4.1 Summary of Project Significance 
Myocardial infarction is one of the leading causes of death in the world. Each 
year, more than 7 million people are estimated to have myocardial infarction.17 
Cardiovascular disease as a whole in the United States had an estimated $316.6 billion 
dollar cost in 2012. As a comparison, in 2012 the estimated cost for cancer was $88.7 
billion dollars in the United States.1 Myocardial infarction and other related heart 
diseases are responsible for a large portion of the estimated cost for cardiovascular 
disease. Despite the outstanding need for more treatment options, the optimal treatment 
method for heart failure remains to be heart transplantation. Unfortunately, heart 
transplantation is a treatment method uncapable of meeting the outstanding need for 
treatment.2 Each year multiple people die while on the waitlist to receive a donor heart. 
Other treatment methods have been shown to prolong life but do not fully restore 
function nor heal the damaged regions of myocardium.3,46   
There is obvious room for improvement and a clear need to develop alternative 
methods for treating congestive heart failure. Our approach is based on cardiovascular 
tissue engineering using acellular heart scaffolds. The end goal of our work is to develop 
a fully recellularized functional tissue engineered heart made from a decellularized 
xenogeneic or cadaveric heart scaffold and a patient’s own cardiac lineage cells. To 
obtain our end goal, each layer and component of the heart must be fully restored on a 
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decellularized scaffold. This project focused on rebuilding the endocardium layer of the 
ventricles inside an acellular heart scaffold. 
 
 4.2 Summary of Advancement Toward Completion of Specific Aims 
4.2.1 Aim 1: To develop and characterize an acellular rabbit myocardial scaffold 
through bi-ventricular perfusion decellularization. 
Whole rabbit hearts were successfully decellularized using a bi-ventricular 
perfusion decellularization system. This procedure yielded four decellularized rabbit 
hearts with preserved ventricular cavity surface structure and shape. Decellularization 
was assessed by color change from native burgundy to decellularized snow-white, DNA 
loss depicted in nanodrop spectrometry, lack of DNA content from gel electrophoresis, 
and the absence of cellular content in images from DAPI fluorescent nuclear stain, 
Masson’s Trichrome stain, and SEM. Masson’s Trichrome stain and SEM images also 
revealed ventricular structure and majority of the extracellular composition was retained. 
However, IHC staining for the basal lamina components depicted partial distribution of 
the basal laminin. 
4.2.2 Aim 2: To reconstitute the endocardium inside the acellular ventricular 
cavities with clinically relevant hydrogels and cell types.  
After sterilizing decellularized rabbit heart scaffolds, collagen and fibrin 
hydrogels, endothelial cells, and fibroblast cells differentiated from ADSCs were 
administered into the ventricles in a layer-by-layer technique. A total of two layers were 
applied to the endocardial surface of the acellular ventricles. The first layer consisted of 
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two collagen hydrogel coatings with fibroblast cells in between to recreate the loose 
collagenous structure of the subendothelial layer of the endocardium. The second layer 
consisted of a fibrin hydrogel coating followed by endothelial cells to rebuild the 
endothelium layer of the endocardium. DAPI fluorescent nuclear stain and Masson’s 
Trichrome stain images revealed cells and hydrogel attached in segmented patches along 
the ventricles’ surfaces. SEM images and images from IHC stained for laminin protein 
supported these findings and additionally showed cells integrated with the hydrogel, 
interacting with neighboring cells, and actively secreting basal lamina proteins. Also, 
histological stains depicted cells and hydrogel infiltrated in some of the pores beneath the 
ventricular surfaces and in the coronary vasculature. Previous cell seeding experiments 
showed acellular rabbit heart scaffolds support cell viability. 
 
 4.3 Recommendations for Future Studies 
4.3.1 Overview  
This research project is aimed at reconstituting the endocardium in ventricular 
cavities of decellularized whole heart scaffolds. The long-term goal is to develop a tissue 
engineered functional whole heart for the transplantation need of patients with an end 
stage heart disease. To continue to work towards this end goal, there are several aspects 
of this project that can be improved upon and further researched. Decellularization of 
whole rabbit hearts, reconstitution of the endocardium, and methodology for obtaining 
results are all areas capable of improving.  
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4.3.2 Decellularization of Whole Rabbit Hearts  
The major drawback of our decellularization procedure is the partial removal and 
disruption of the basal lamina. Literature reports have suggested the use of detergents in 
decellularization have resulted in the removal or disruption of extracellular matrix 
components.60 Our procedure utilizes 5 cycles of SDS rinses with each cycle lasting four 
days at a time. Jessica Canavan (2016) previously worked on decellularizing whole rabbit 
hearts. She decellularized more than 4 rabbit hearts at once while only perfusing into the 
left ventricle. Her decellularization procedure used the same concentration of SDS and 
number of days per SDS cycle as our decellularization procedure. After completing 
decellularization, her work suggested only three cycles of SDS were needed to effectively 
decellularize multiple left ventricles of whole rabbit hearts.91 Our decellularization 
system perfuses fluids into both ventricles of four rabbit hearts. One possible method for 
improving the basal lamina retention of our scaffolds, would be to reduce the number of 
SDS cycles until the minimum is used for effectively decellularizing the whole rabbit 
hearts. DNA content should be assessed after each SDS cycle by a combination of 
techniques using either color change, nanodrop spectrometry, gel electrophoresis, 
histology, or SEM. 
 
4.3.3 Reconstitution of the Endocardium 
There are two areas of improvement for reconstituting the endocardium. The first 
is improving the layer-by-layer method to increase hydrogel and cellular attachment and 
uniformity across the ventricular surfaces. Several methods can be explored for 
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improving this aspect. One method is incorporating electrostatic interactions when 
applying the collagen hydrogel. Literature reports indicate several techniques have been 
used for attracting each layer of a layer-by-layer method such as charge transfer, 
biological recognition, covalent or hydrogen bonding, and electrostatic or hydrophobic 
interactions.104 Utilizing electrostatic interactions could be accomplished by incubating 
the scaffold in a basic solution followed by adjusting the pH of the collagen hydrogel to 
be acidic. Once collagen proteins are past their isoelectric point, they will develop an 
affinity for accepting electrons. After incubating the scaffold in a basic solution, the 
positively charged collagen proteins would be attracted to the electron donor molecules 
embedded in the scaffold. This may influence the collagen proteins to infiltrate the 
surface of the scaffold more intimately before solidification. Careful consideration would 
need to be taken to not damage, degrade, or alter the scaffold and collagen hydrogel. 
Additionally, the hydrogel infused scaffold would need to be neutralized to be compatible 
with cell seeding.  
Another route for improving collagen hydrogel infusion is to decrease the 
concentration of collagen protein in the hydrogel solution and let the solution set 
overnight in the ventricles to solidify. This approach is analogous to our method for 
creating the fibrin hydrogel on the surfaces of the ventricles. The collagen hydrogel 
solution would be rotated and centrifuged inside ventricles of the acellular scaffold for 
uniformity and solidification on the surface. The small concentration of collagen proteins 
would ideally be centrifuged to the surface of the ventricles to create a layer of collagen 
hydrogel after overnight incubation.  
 148 
Methods that can be explored for improving cell viability are reducing the number 
of endothelial cells seeded at once and reducing the incubation time the cells are sealed 
inside the ventricles for cellular attachment. Seeding millions of endothelial cells at once 
may be determinantal to cell viability because of the limited availability of nutrients. 
Because the ventricles were sealed for overnight incubation to ensure the seeded cells do 
not flow out of the ventricles, the media in the cell suspension may not contain enough 
nutrients to support the large number of seeded cells for the duration of time. Reducing 
the number of cells seeded at once may improve cell viability by not utilizing the 
available nutrients as quickly. Seeding steps could be repeated to ensure millions of 
endothelial cells are still seeded into the ventricles. Reducing the incubation time from 
overnight to 4-6 hours would still allow enough time for cellular attachment while 
reducing the time span the seeded cells are sealed off from the available nutrients and 
oxygen in the media stored inside the bioreactor. 
Development and implementation of a perfusion bioreactor would also improve 
endocardium reconstitution. The rotation bioreactor system is capable of supporting cell 
viability to an extent. Eventually, media flow will be needed to support cell proliferation 
and viability for longer-term studies. Additionally, introducing flow to the patches of 
reconstituted endocardium will explore the effect of shear on the durability of the 
reconstituted endocardium. Also, experiments will need to be performed for longer 
durations to discover the final condition of the reconstituted endocardium after the seeded 
cells have degraded the fibrin hydrogel and secreted basal lamina proteins. Ideally, the 
perfusion bioreactor would start at low flow and ramp up to physiological conditions. 
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Incorporating pulsatile flow and a method for inducing ventricular contractions, would 
further improve scaffold conditioning. For our reconstituted endocardium to have clinical 
relevance, the reconstituted endocardium must be able to withstand physiological 
conditions.  
Additionally, to show clinical relevance, the scaffold will need to be mechanically 
tested. Assessing mechanical performance was not done in our study but is highly 
recommended in future studies, especially after the development of a perfusion 
bioreactor. Mechanical testing would verify the reconstituted endocardium and scaffold 
itself can withstand physiological stresses and function under in vivo conditions. Also, 
mechanical stimulation could be incorporated during the experimental procedure. 
Mechanically stimulating the hydrogels may improve solidification uniformity along the 
surface of the ventricles and condition the scaffold prior to assessing mechanical 
performance.      
In our study, we showed hydrogels and cells seeded into the coronary vasculature 
and myocardial pores produced a favorable environment for cells to secrete structure 
proteins. While this helps replenish some of the basal lamina proteins lost during 
decellularization, infusing hydrogels into the coronary vasculature is not ideal. Seeding 
vascular cell lines into the coronary vasculature will eventually be needed for 
recellularizing the whole myocardial scaffold but infusing hydrogels into the coronary 
vasculature may occlude some of the vascular network depending on how well cells can 
degrade and restructure the hydrogels. One method for preventing hydrogels from 
entering the coronary vasculature would be to design and implement a longer cannula for 
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cannulating the aorta. The longer cannula would need to bypass the aortic valve and 
administer the hydrogels directly into the left ventricle. Another method for preventing 
the hydrogels from entering the coronaries is ligating the coronaries prior to 
administering the hydrogels.  
 
4.3.4 Methodology for Obtaining Results 
All histology, IHC, and SEM data gathered across every experiment was 
performed on scaffolds or hearts fixed static in formalin. In vivo, the heart is under 
pressure from blood perfusion. To adequately ascertain the results from decellularization 
and reconstitution experiments, scaffolds should be perfusion fixed in formalin and 
compared to native hearts perfusion fixed in formalin. This will yield representative 
images of the endocardium seen under natural conditions.  
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